TW201309751A - Photoactive crosslinking compound, method for preparing the same, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device - Google Patents

Photoactive crosslinking compound, method for preparing the same, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device Download PDF

Info

Publication number
TW201309751A
TW201309751A TW101122507A TW101122507A TW201309751A TW 201309751 A TW201309751 A TW 201309751A TW 101122507 A TW101122507 A TW 101122507A TW 101122507 A TW101122507 A TW 101122507A TW 201309751 A TW201309751 A TW 201309751A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
compound
bis
chemical formula
crystal alignment
Prior art date
Application number
TW101122507A
Other languages
Chinese (zh)
Inventor
Seng-Kue Lee
Jin-Wook Choi
Yong-Ho Ahn
Sang-Wan So
Original Assignee
Dongjin Semichem Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dongjin Semichem Co Ltd filed Critical Dongjin Semichem Co Ltd
Publication of TW201309751A publication Critical patent/TW201309751A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/15Heterocyclic compounds having oxygen in the ring
    • C08K5/151Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
    • C08K5/1515Three-membered rings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/17Amines; Quaternary ammonium compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/13378Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by treatment of the surface, e.g. embossing, rubbing or light irradiation
    • G02F1/133788Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by treatment of the surface, e.g. embossing, rubbing or light irradiation by light irradiation, e.g. linearly polarised light photo-polymerisation
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133742Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers for homeotropic alignment

Abstract

The present invention relates to a photoactive crosslinker compound, to a method for preparing same, to a liquid crystal aligning agent, to a liquid crystal aligning film, and to a liquid crystal display device. More particularly, the present invention relates to the photoactive crosslinker compound having a novel structure, to the method for preparing same, to the liquid crystal aligning agent, to the liquid crystal aligning film, and to the liquid crystal display device. According to the present invention, the liquid crystal aligning agent has high vertical alignment performance, good storage stability, superior transparency, and excellent liquid crystal aligning properties, printability, and electrical characteristics. Further, the stability of a pretilt angle and strength of the film can be improved, and a pretilt of a liquid crystal can be formed by UV exposure alone.

Description

光活性交聯化合物、其製備方法、液晶配向劑、液晶配向 膜、以及液晶顯示裝置 Photoactive crosslinking compound, preparation method thereof, liquid crystal alignment agent, liquid crystal alignment Film, and liquid crystal display device

本發明涉及一種光活性交聯化合物、其製備方法、液晶配向劑,液晶配向膜、以及液晶顯示裝置。更具體地,涉及一種具有新結構之光活性交聯化合物、其製備方法、液晶配向劑、液晶配向膜、以及液晶顯示裝置。 The present invention relates to a photoactive crosslinking compound, a method for producing the same, a liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device. More specifically, it relates to a photoactive crosslinking compound having a novel structure, a method for producing the same, a liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device.

本申請對2011年6月23日提交至韓國特許廳之韓國特許第10-2011-0061213號之專利申請主張優先權及享有其權益,該申請案的全部內容併入本案以資參照。 The present application claims priority to and the benefit of the Korean Patent Application No. 10-2011-0061213, filed on Jun.

在液晶顯示器之結構材料中,液晶配向膜與液晶分子接觸,藉以使液晶分子均勻配向。液晶配向膜為驅動液晶之核心材料,使液晶朝向一側均勻配向,致使液晶能夠好好地執行作為偏光光線之開關作用,且液晶配向膜之液晶配向特性及作為薄膜之電特性會決定液晶顯示器的顯示品質。 In the structural material of the liquid crystal display, the liquid crystal alignment film is in contact with the liquid crystal molecules, thereby uniformly aligning the liquid crystal molecules. The liquid crystal alignment film is the core material for driving the liquid crystal, so that the liquid crystal is uniformly aligned toward one side, so that the liquid crystal can perform the switching function as the polarized light well, and the liquid crystal alignment characteristics of the liquid crystal alignment film and the electrical characteristics of the film determine the liquid crystal display. Display quality.

形成液晶配向膜之代表性方法有無機物之傾斜沉積法、朗穆爾-布拉傑特(Langmuir-Blodgett,LB)法、高分子延伸法、摩擦法等,作為新的配向方法,被提出的有光配向法及離子束照射法等。其中最普遍應用的方法係採用布摩擦基板表面之摩擦(rubbing)法。摩擦法係指用紙沿規定的方向摩擦玻璃基板,使液晶分子之長軸沿著其摩擦方向整齊排列並配向之方法。由於此種摩擦法配向處理容易,適於大量生產,並具有配向穩定、預傾(pretilt)角控制容易之 優點,因此為工業上使用最多的配向方法。 Representative methods for forming a liquid crystal alignment film include an oblique deposition method of an inorganic substance, a Langmuir-Blodgett (LB) method, a polymer stretching method, a rubbing method, etc., as a new alignment method. There are photo-alignment method and ion beam irradiation method. One of the most commonly used methods is the rubbing method of rubbing the surface of the substrate with a cloth. The rubbing method refers to a method in which paper is rubbed in a predetermined direction to rub the glass substrate so that the long axes of the liquid crystal molecules are aligned and aligned along the rubbing direction thereof. Because the friction method is easy to handle, it is suitable for mass production, and has an orientation stabilization and pretilt angle control. The advantage is therefore the most used alignment method in the industry.

作為配向膜之材料,使用最多的為介電常數低、熱穩定性高、機械強度優秀、以及製程性卓越之聚醯亞胺。但是,將聚醯亞胺作為配向膜材料存在如下問題或者缺點。第一,由於靜電可能會破壞薄膜電晶體(TFT)裝置,因此生產機械一般都會針對靜電問題有所對策,然而,摩擦法具有無法針對在配向過程中所生成之靜電提供完整解決方案的缺點。第二,透過摩擦法進行配向的過程中可能會產生粉塵,因此需要進行後續的清潔製程,使得製程過程中可能會出現效率降低的問題。第三,具有階梯部之排列層的平面部,與階梯部之摩擦條件不同,致使其發生對準固定力和傾角不均勻的可能性高。第四,由於過程中只沿一個方向摩擦,致使具有被分離之配向像素之排列層的生產製程變得複雜。更且,為了能夠均勻摩擦大型基板,還需要特殊設備。 As the material of the alignment film, the most used polyimine which has a low dielectric constant, high thermal stability, excellent mechanical strength, and excellent processability. However, the use of polyimine as an alignment film material has the following problems or disadvantages. First, since static electricity may damage thin film transistor (TFT) devices, production machines generally have countermeasures against electrostatic problems. However, the friction method has the disadvantage of not providing a complete solution to the static electricity generated during the alignment process. Second, dust may be generated during the alignment by the rubbing method, so a subsequent cleaning process is required, which may cause a problem of reduced efficiency during the process. Third, the flat portion having the alignment layer of the step portion is different from the friction condition of the step portion, so that the possibility of occurrence of alignment fixing force and uneven inclination is high. Fourth, since the process is only rubbed in one direction, the manufacturing process of the alignment layer having the separated alignment pixels becomes complicated. Moreover, in order to be able to uniformly rub a large substrate, special equipment is also required.

為了克服前揭缺點,目前正興起一種光配向技術,其係在無摩擦狀態下,僅透過將偏光之紫外線(UV)照射於高分子膜,就能夠製備液晶配向膜。光配向技術利用之原理為透過引起光反應,在膜上產生光學各向異性。因此,為利用液晶光配向控制技術,需使用具有直線偏光方向性的光,並需要光致異構化、光聚合或者光解等高分子膜之光反應過程,且要求照射之光的偏光方向能夠控制液晶分子之方向等多個條件。 In order to overcome the shortcomings of the prior art, a light alignment technique is being developed in which a liquid crystal alignment film can be prepared by irradiating only a polarized ultraviolet (UV) light onto a polymer film in a frictionless state. The principle of light alignment technology is to produce optical anisotropy on the film by causing a photoreaction. Therefore, in order to utilize the liquid crystal light alignment control technology, it is necessary to use light having a linear polarization directivity, and a photoreaction process of a polymer film such as photoisomerization, photopolymerization or photolysis is required, and the polarization direction of the irradiated light is required. It is possible to control a plurality of conditions such as the direction of liquid crystal molecules.

一般在垂直配向液晶模式(Vertical Alignment Liquid Crystal Mode)中,為了使由視角引起之亮度變化降至最低,應形成多區域(multi-domain),是故需要多配向處理方式,但摩擦配向方式無法以微米單位調整配向範圍,而必須利用在上下基板上形成電極圖案或者形成突起之方式來解決。然而上述兩種方式需要額外製程,且存在有諸如響應速度或者初期漏光之電光學特性問題等缺點。 Generally in vertical alignment liquid crystal mode (Vertical Alignment Liquid In Crystal Mode, in order to minimize the change in brightness caused by the angle of view, multi-domain should be formed. Therefore, multi-alignment processing is required, but the rubbing alignment method cannot adjust the alignment range in micrometer units, but must be utilized. It is solved by forming an electrode pattern on the upper and lower substrates or forming protrusions. However, the above two methods require an additional process, and there are disadvantages such as a response speed or an electro-optical characteristic problem of initial light leakage.

因此,需要一種能夠解決現有光學圖案形成製程之經濟性不佳、環境親和性不足、穩定性不佳以及所製備之光學圖案會導致產品性能降低等問題的方案。 Therefore, there is a need for a solution that can solve the problems of poor economics of the existing optical pattern forming process, insufficient environmental affinity, poor stability, and reduced optical performance of the prepared optical pattern.

為解決現有液晶配向方法中所存在之問題,本發明之目的在於提供一種用於製備液晶配向劑的新光活性交聯化合物,該液晶配向劑採用在無摩擦狀態下使液晶分子排列的方法,亦即光配向技術,在其形成配向膜之後仍具有優秀的熱穩定性,且在照射紫外線之後還能實現高配向性和穩定性。 In order to solve the problems existing in the prior art liquid crystal alignment method, the object of the present invention is to provide a novel photoactive crosslinking compound for preparing a liquid crystal alignment agent, which is a method for aligning liquid crystal molecules in a frictionless state. That is, the photo-alignment technique has excellent thermal stability after it forms an alignment film, and can achieve high alignment and stability after irradiation of ultraviolet rays.

此外,本發明之目的在於提供一種該光活性交聯化合物之製備方法。 Further, it is an object of the present invention to provide a process for producing the photoactive crosslinking compound.

另外,本發明之目的在於提供一種液晶配向劑,該液晶配向劑包括該光活性交聯化合物,以及聚醯胺酸或者聚醯亞胺。 Further, it is an object of the present invention to provide a liquid crystal alignment agent comprising the photoactive crosslinking compound, and polylysine or polyimine.

再者,本發明之目的在於提供一種由該液晶配向劑所形成之液晶配向膜。 Furthermore, it is an object of the present invention to provide a liquid crystal alignment film formed of the liquid crystal alignment agent.

更且,本發明之目的在於提供一種具該液晶配向膜之液晶顯示裝置。 Furthermore, it is an object of the present invention to provide a liquid crystal display device having the liquid crystal alignment film.

為達到上述目的,本發明提供一種由下列化學式I表示之光活性交聯化合物。 In order to achieve the above object, the present invention provides a photoactive crosslinking compound represented by the following Chemical Formula I.

該化學式I中,X1、X2、X3及X4中任意一個以上為,其餘為H;R1至R8為相同或者相異,且分別獨立地為選自H、CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個;A為或者B為或者n為1至20之整數。 In the chemical formula I, any one of X 1 , X 2 , X 3 and X 4 is And the rest are H; R 1 to R 8 are the same or different, and are independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, an alkyl group having 1 to 10 carbon atoms, and a carbon number. Any one of 1 to 10 alkoxy groups; A is or B is or n is an integer from 1 to 20.

另外,本發明提供一種由下列化學式II表示之光活性 交聯化合物。 Further, the present invention provides a photoactive activity represented by the following Chemical Formula II Cross-linking compounds.

該化學式II中,X1、X2、X3及X4中任意一個以上為,其餘為H;R1至R8為相同或者相異,且分別獨立地為選自H、CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個;A為或者B為或者n為1至20之整數。 In the chemical formula II, any one of X 1 , X 2 , X 3 and X 4 is And the rest are H; R 1 to R 8 are the same or different, and are independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, an alkyl group having 1 to 10 carbon atoms, and a carbon number. Any one of 1 to 10 alkoxy groups; A is or B is or n is an integer from 1 to 20.

另外,本發明提供一種液晶配向劑,包括有該光活性交聯化合物,以及聚醯胺酸或者聚醯亞胺。 Further, the present invention provides a liquid crystal alignment agent comprising the photoactive crosslinking compound, and polyamic acid or polyimine.

此外,本發明提供一種由該液晶配向劑形成之液晶配向膜。 Further, the present invention provides a liquid crystal alignment film formed of the liquid crystal alignment agent.

另外,本發明提供一種具有該液晶配向膜之液晶顯示裝置。 Further, the present invention provides a liquid crystal display device having the liquid crystal alignment film.

另一方面,本發明提供一種由下列化學式20表示之光活性交聯化合物之製備方法,包括使下列化學式19表示之化合物與下列化學式5表示之化合物反應的步驟。 In another aspect, the present invention provides a process for producing a photoactive crosslinking compound represented by the following Chemical Formula 20, which comprises the step of reacting a compound represented by the following Chemical Formula 19 with a compound represented by the following Chemical Formula 5.

該化學式5、19及20中,R1至R8為相同或者相異,且分別獨立地為選自H、 CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個;n為1至20之整數。 In the chemical formulas 5, 19 and 20, R 1 to R 8 are the same or different, and are each independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, an alkyl group having 1 to 10 carbon atoms, And any one of alkoxy groups having 1 to 10 carbon atoms; n is an integer of 1 to 20.

再者,本發明提供一種由下列化學式40表示之光活性交聯化合物之製備方法,包括使下列化學式39表示之化合物與下列化學式28表示之化合物反應的步驟。 Furthermore, the present invention provides a process for producing a photoactive crosslinking compound represented by the following Chemical Formula 40, which comprises the step of reacting a compound represented by the following Chemical Formula 39 with a compound represented by the following Chemical Formula 28.

該化學式28、39及40中,R1至R4為相同或者相異,且分別獨立地為選自H、CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個;n為1至20之整數。 In the chemical formulas 28, 39 and 40, R 1 to R 4 are the same or different, and are each independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, an alkyl group having 1 to 10 carbon atoms, And any one of alkoxy groups having 1 to 10 carbon atoms; n is an integer of 1 to 20.

由於本發明係透過利用一種在無摩擦狀態下使液晶分子進行排列的光配向技術,因此能夠確保製程過程之安全性和經濟性,並能夠提供具環保性的製程。 Since the present invention utilizes a light alignment technique for aligning liquid crystal molecules in a frictionless state, it is possible to ensure the safety and economy of the process, and to provide an environmentally friendly process.

本發明之包含有光活性交聯化合物之液晶配向劑,能夠進一步提高液晶配向膜之預傾角的穩定性以及膜強度,且由於僅需以UV曝光就能夠實現液晶的預傾,因此能夠提供簡易的製程過程,藉以降低生產成本以及提高產率。 The liquid crystal alignment agent containing the photoactive crosslinking compound of the present invention can further improve the stability of the pretilt angle of the liquid crystal alignment film and the film strength, and can realize the pretilt of the liquid crystal only by UV exposure, thereby providing simplicity Process to reduce production costs and increase productivity.

另外,本發明能夠提供一種液晶配向劑,其具有垂直配向性能高、保存穩定性良好、透明性優秀以及液晶配向性、印刷性及電特性卓越等特點。 Further, the present invention can provide a liquid crystal alignment agent which has high vertical alignment performance, good storage stability, excellent transparency, and excellent liquid crystal alignment, printability, and electrical characteristics.

【圖式簡單說明】 [Simple description of the map]

圖1顯示由本發明之實施例3所製備之液晶顯示裝置的液晶配向照片。 Fig. 1 is a view showing a liquid crystal alignment photograph of a liquid crystal display device prepared in Example 3 of the present invention.

圖2顯示由比較例1所製備之液晶顯示裝置的液晶配向照片。 2 shows a liquid crystal alignment photograph of the liquid crystal display device prepared in Comparative Example 1.

由本發明之光活性交聯化合物製備之液晶配向劑,可以不需進行摩擦處理,而利用將偏光之紫外線(UV)照射於高分子膜的光配向技術來製備液晶配向膜。 The liquid crystal alignment agent prepared from the photoactive crosslinking compound of the present invention can prepare a liquid crystal alignment film by a light alignment technique of irradiating ultraviolet light (UV) on a polymer film without performing a rubbing treatment.

光配向技術利用之原理為透過引起光反應,在膜上產生光學各向異性。因此,為利用液晶光配向控制技術,需使用具有直線偏光方向性的光,並需要光致異構化、光聚合或者光解等高分子膜之光反應過程,且要求所照射之光的偏光方向能夠控制液晶分子之方向等多個條件。 The principle of light alignment technology is to produce optical anisotropy on the film by causing a photoreaction. Therefore, in order to utilize the liquid crystal light alignment control technology, it is necessary to use light having a linear polarization directivity, and a photoreaction process of a polymer film such as photoisomerization, photopolymerization or photolysis is required, and polarization of the irradiated light is required. The direction can control a plurality of conditions such as the direction of the liquid crystal molecules.

光致異構化反應具有會受到逆反應影響之缺點,在光解反應中存在有由分解生成物引起之液晶層污染等缺點。對於光聚合反應,雖然最初探討了聚(乙烯基肉桂酯)(poly(vinyl cinnamate))類高分子,但由於所使用之紫外線的波長短,因此具有難以使用通用之大型曝光裝置來大量生產的問題。 The photoisomerization reaction has a disadvantage that it is affected by the reverse reaction, and there are disadvantages such as contamination of the liquid crystal layer by the decomposition product in the photolysis reaction. In the photopolymerization reaction, a poly(vinyl cinnamate) polymer was first explored. However, since the wavelength of the ultraviolet ray used is short, it is difficult to mass-produce it using a general-purpose large-scale exposure apparatus. problem.

一般常用來作為光配向劑之聚醯亞胺樹脂係指,將芳 香族四羧酸或其衍生物和芳香族二胺或者芳香族二異氰酸酯縮聚後,再進行醯亞胺化所製得之高耐熱性樹脂。 Polyimide resin commonly used as a photo-aligning agent means After the polycondensation of the aromatic tetracarboxylic acid or its derivative with an aromatic diamine or an aromatic diisocyanate, the high heat resistant resin obtained by oxime imidization is further subjected.

聚醯亞胺樹脂依據所使用之單體種類,可具有多種分子結構。一般來說,作為芳香族四羧酸成分係使用苯均四甲酸二酐(PMDA)或者聯苯四羧酸二酐(BPDA);作為芳香族二胺成分係使用對-苯二胺(p-PDA)、間-苯二胺(m-PDA)、4,4’-二胺基二苯醚(ODA)、4,4’-二胺基二苯甲烷(MDA)、2,2’-雙胺基苯六氟丙烷(2,2’-bisamino phenyl hexafluoropropane,HFDA)、間-雙胺基苯氧基二苯碸(m-BAPS)、對-雙胺基苯氧基二苯碸(p-BAPS)、1,4-雙(4-胺基苯氧基)苯(TPE-Q)、1,3-雙(4-胺基苯氧基)苯(TPE-R)、2,2’-[4-(4-雙胺基苯氧基)苯基]丙烷(BAPP)、以及2,2’-雙[4-(4-胺基苯氧基)苯基]六氟丙烷(HFBAPP)等。 Polyimine resins can have a variety of molecular structures depending on the type of monomer used. Generally, as the aromatic tetracarboxylic acid component, pyromellitic dianhydride (PMDA) or biphenyltetracarboxylic dianhydride (BPDA) is used; as the aromatic diamine component, p-phenylenediamine (p-) is used. PDA), m-phenylenediamine (m-PDA), 4,4'-diaminodiphenyl ether (ODA), 4,4'-diaminodiphenylmethane (MDA), 2,2'-double 2,2'-bisamino phenyl hexafluoropropane (HFDA), m-bisaminophenoxydiphenyl hydrazine (m-BAPS), p-diaminophenoxydiphenyl hydrazine (p- BAPS), 1,4-bis(4-aminophenoxy)benzene (TPE-Q), 1,3-bis(4-aminophenoxy)benzene (TPE-R), 2,2'- [4-(4-Diaminophenoxy)phenyl]propane (BAPP), and 2,2'-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane (HFBAPP), etc. .

一般在垂直配向液晶模式(Vertical Alignment Liquid Crystal Mode)中,為了使由視角引起之亮度變化降至最低,應形成多區域(multi-domain),是故需要多配向處理方式,但摩擦配向方式無法以微米單位調整配向範圍,而必須利用在上下基板上形成電極圖案或者形成突起之方式來解決。然而上述兩個方式需要額外製程,且存在有諸如響應速度或者初期漏光之電光學特性問題等缺點。 Generally, in the Vertical Alignment Liquid Crystal Mode, in order to minimize the change in luminance caused by the viewing angle, a multi-domain should be formed, so that a multi-alignment processing method is required, but the friction alignment method cannot The alignment range is adjusted in micrometer units, and must be solved by forming an electrode pattern on the upper and lower substrates or forming protrusions. However, the above two methods require an additional process, and there are disadvantages such as a response speed or an electro-optic characteristic problem of initial light leakage.

本發明之目的在於提供一種光活性交聯化合物以及包括該化合物的液晶配向劑,該化合物透過使用這種光配向技術,實現液晶顯示裝置中的液晶分子排列,藉此在形成配向膜後,僅以UV曝光就能夠實現預傾。 An object of the present invention is to provide a photoactive crosslinking compound and a liquid crystal alignment agent comprising the same, which can realize alignment of liquid crystal molecules in a liquid crystal display device by using such a photoalignment technique, whereby after forming an alignment film, only Pretilt can be achieved with UV exposure.

在本說明書中之特定術語係為了向本領域技術人員詳細說明本發明而使用,並不是用以限定含義或者限定在申請專利範圍中所記載之本發明之範圍。 The specific terms used in the specification are used to describe the invention to those skilled in the art, and are not intended to limit the scope of the invention or the scope of the invention described in the claims.

下面,參照實施例進一步詳細說明本發明之光活性交聯化合物及其製備方法、液晶配向劑、液晶配向膜及液晶顯示裝置。然而,本發明之多個實施例可變換為其他多種形態,不應解釋為本發明之範圍侷限於下述實施例。本發明所提供的多個實施例僅係為了向本領域中具有通常知識者更完整地說明本發明。 Hereinafter, the photoactive crosslinking compound of the present invention, a method for producing the same, a liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device will be described in further detail with reference to examples. However, the various embodiments of the invention may be modified into other various forms, and the scope of the invention should not be construed as being limited to the embodiments described below. The various embodiments of the present invention are intended to provide a more complete description of the invention.

光活性交聯化合物及其製備方法Photoactive crosslinking compound and preparation method thereof

根據本發明之一方面,本發明之光活性交聯化合物能夠以下列化學式I表示。 According to an aspect of the invention, the photoactive crosslinking compound of the invention can be represented by the following chemical formula I.

該化學式I中,X1、X2、X3及X4中任意一個以上為,其餘為H;R1至R8為相同或者相異,且分別獨立地為選自H、CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個; A為或者B為或者n為1至20之整數。 In the chemical formula I, any one of X 1 , X 2 , X 3 and X 4 is And the rest are H; R 1 to R 8 are the same or different, and are independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, an alkyl group having 1 to 10 carbon atoms, and a carbon number. Any one of 1 to 10 alkoxy groups; A is or B is or n is an integer from 1 to 20.

根據本發明之一實施例,該化學式I中,R1至R8可為H,n可為1至5之整數。 According to an embodiment of the present invention, in the formula I, R1 to R8 may be H, and n may be an integer of 1 to 5.

根據本發明之一實施例,該化學式I之化合物可以是例如以下列化學式20、化學式22或者化學式24表示之化合物。 According to an embodiment of the present invention, the compound of the formula I may be, for example, a compound represented by the following Chemical Formula 20, Chemical Formula 22 or Chemical Formula 24.

該化學式20中,R1至R8為相同或者相異,且分別獨立地為選自H、CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個;n為1至20之整數。 In the formula 20, R 1 to R 8 are the same or different, and are each independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, an alkyl group having 1 to 10 carbon atoms, and a carbon number. Any one of 1 to 10 alkoxy groups; n is an integer of 1 to 20.

根據本發明之另一方面,提供一種以該化學式20表示之光活性交聯化合物之製備方法。 According to another aspect of the present invention, there is provided a process for producing a photoactive crosslinking compound represented by the Chemical Formula 20.

以該化學式20表示之光活性交聯化合物之製備方法,包括使下列化學式19表示之化合物與下列化學式5表示之化合物反應之步驟。 The method for producing a photoactive crosslinking compound represented by the chemical formula 20 includes a step of reacting a compound represented by the following Chemical Formula 19 with a compound represented by the following Chemical Formula 5.

在該化學式5、19及20中,R1至R8為相同或者相異,且分別獨立地為選自H、CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個;n為1至20之整數。 In the chemical formulas 5, 19 and 20, R 1 to R 8 are the same or different, and are each independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, and an alkyl group having 1 to 10 carbon atoms. And one of alkoxy groups having 1 to 10 carbon atoms; n is an integer of 1 to 20.

更具體地,以該化學式20表示之光活性交聯化合物之製備方法,可透過逐步執行下列反應式1、2、3、4及5而製備,然而,本發明並不限於此。 More specifically, the preparation method of the photoactive crosslinking compound represented by the Chemical Formula 20 can be produced by gradually performing the following Reaction Formulas 1, 2, 3, 4 and 5, however, the present invention is not limited thereto.

該反應式1至5中,R1至R8以及n係與該化學式I所定義者相同。 In the reaction formulae 1 to 5, R 1 to R 8 and n are the same as those defined in the chemical formula I.

該反應式1至5中所使用的原料化合物、中間化合物以及生成化合物能夠以下列化學式1至24表示。 The starting compound, the intermediate compound, and the resulting compound used in the reaction formulae 1 to 5 can be represented by the following Chemical Formulas 1 to 24.

該化學式1至24中,R1至R8以及n係與該化學式I所定義者相同。 In the chemical formulae 1 to 24, R 1 to R 8 and n are the same as those defined in the chemical formula I.

而且,在該反應式1至5中,能夠使用化學式21及23之化合物代替化學式6之化合物,並透過與該反應式1至5類似之方法,分別製備該化學式22及化學式24之化合物。 Further, in the above Reaction Formulas 1 to 5, the compounds of Chemical Formulas 21 and 23 can be used instead of the compound of Chemical Formula 6, and the compounds of Chemical Formula 22 and Chemical Formula 24 can be separately produced by a method similar to the Reaction Formulas 1 to 5.

根據本發明之另一方面,本發明之光活性交聯化合物能夠以下列化學式II表示。 According to another aspect of the present invention, the photoactive crosslinking compound of the present invention can be represented by the following Chemical Formula II.

該化學式II中, X1、X2、X3及X4中任意一個以上為,其餘為H;R1至R8為相同或者相異,且分別獨立地為選自H、CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個;A為或者B為或者n為1至20之整數。 In the chemical formula II, any one of X 1 , X 2 , X 3 and X 4 is And the rest are H; R 1 to R 8 are the same or different, and are independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, an alkyl group having 1 to 10 carbon atoms, and a carbon number. Any one of 1 to 10 alkoxy groups; A is or B is or n is an integer from 1 to 20.

根據本發明之一實施例,該化學式II中,R1至R8為H,n可為1至5之整數。 According to an embodiment of the present invention, in the formula II, R 1 to R 8 are H, and n may be an integer of 1 to 5.

根據本發明之一實施例,該化學式II之化合物能夠以下列化學式40表示。 According to an embodiment of the present invention, the compound of the formula II can be represented by the following chemical formula 40.

該化學式40中,R1至R4為相同或者相異,且分別獨立地為選自H、CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個;n為1至20之整數。 In the formula 40, R 1 to R 4 are the same or different, and are each independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, an alkyl group having 1 to 10 carbon atoms, and a carbon number. Any one of 1 to 10 alkoxy groups; n is an integer of 1 to 20.

根據本發明之另一方面,提供一種以該化學式40表示之光活性交聯化合物之製備方法。 According to another aspect of the present invention, there is provided a process for producing a photoactive crosslinking compound represented by the Chemical Formula 40.

以該化學式40表示之光活性交聯化合物之製備方法,包括使下列化學式39表示之化合物與下列化學式28表示之化合物反應之步驟。 The method for producing a photoactive crosslinking compound represented by the chemical formula 40 includes a step of reacting a compound represented by the following Chemical Formula 39 with a compound represented by the following Chemical Formula 28.

在該化學式28、39及40中, R1至R4為相同或者相異,且分別獨立地為選自H、CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個;n為1至20之整數。 In the chemical formulas 28, 39 and 40, R 1 to R 4 are the same or different, and are each independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, and an alkyl group having 1 to 10 carbon atoms. And one of alkoxy groups having 1 to 10 carbon atoms; n is an integer of 1 to 20.

更具體地,以該化學式40表示之光活性交聯化合物之製備方法,可透過執行下列反應式6及7而製備,但本發明並不限於此。 More specifically, the method for producing the photoactive crosslinking compound represented by the chemical formula 40 can be produced by performing the following Reaction Formulas 6 and 7, but the present invention is not limited thereto.

該反應式6及7中,R1至R4以及n係與該化學式II所定義者相同。 In the reaction formulas 6 and 7, R 1 to R 4 and n are the same as those defined in the chemical formula II.

該反應式6及7中所使用的原料化合物、中間化合物以及生成化合物能夠以下列化學式25至40表示。 The starting compound, the intermediate compound, and the resulting compound used in the reaction formulas 6 and 7 can be represented by the following Chemical Formulas 25 to 40.

該化學式25至40中,R1至R4以及n係與該化學式II所定義者相同。 In the chemical formulae 25 to 40, R 1 to R 4 and n are the same as those defined in the chemical formula II.

上述本發明之新光活性交聯化合物能夠進一步提高液晶配向膜之預傾角的穩定性以及膜強度。更具體而言,透 過在聚醯胺酸或者聚醯亞胺添加本發明之光活性交聯化合物而製備液晶配向劑時,能夠進一步提高液晶配向膜之預傾角的穩定性以及膜強度。 The above novel photoactive crosslinking compound of the present invention can further improve the stability of the pretilt angle of the liquid crystal alignment film and the film strength. More specifically, When a liquid crystal alignment agent is prepared by adding the photoactive crosslinking compound of the present invention to polyacrylic acid or polyimine, the stability of the pretilt angle of the liquid crystal alignment film and the film strength can be further improved.

液晶配向劑Liquid crystal alignment agent

本發明提供一種液晶配向劑,其包括有上述之光活性交聯化合物;以及聚醯胺酸或者聚醯亞胺。 The present invention provides a liquid crystal alignment agent comprising the above photoactive crosslinking compound; and polylysine or polyimine.

該聚醯胺酸可透過使二胺類化合物與四羧酸二酐反應而獲得;該聚醯亞胺可透過將聚酰胺酸脫水閉環,以進行醯亞胺化而獲得。 The polyperuric acid is obtained by allowing a diamine compound to react with a tetracarboxylic dianhydride, which is obtained by dehydrating a ring-shaped polyamic acid to carry out oxime imidization.

根據本發明之一實施例,相對於該聚醯胺酸或者聚醯亞胺100重量份,該液晶配向劑可包括0.1至40重量份之該光活性交聯化合物,優選地,可包括0.1至30重量份之該光活性交聯化合物。 According to an embodiment of the present invention, the liquid crystal alignment agent may include 0.1 to 40 parts by weight of the photoactive crosslinking compound, and may preferably include 0.1 to 100 parts by weight of the polyamic acid or polyimine. 30 parts by weight of the photoactive crosslinking compound.

在本發明中,為獲得聚醯胺酸可使用之該二胺類化合物例如為選自由p-苯二胺、m-苯二胺、4,4’-二胺基二苯甲烷、4,4’-二胺基二苯乙烷、4,4’-二胺基二苯硫醚、4,4’-二胺基二苯碸、3,3’-二甲基-4,4’-二胺基聯苯、4,4’-二胺基苯醯替苯胺、4,4’-二胺基二苯醚、1,5-二胺基萘、2,2’-二甲基-4,4’-二胺基聯苯、5-胺基-1-(4’-胺基苯)-1,3,3-三甲基茚滿、6-胺基-1-(4’-胺基苯)-1,3,3-三甲基茚滿、3,4’-二胺基二苯醚、3,3’-二胺基二苯甲酮、3,4’-二胺基二苯甲酮、4,4’-二胺基二苯甲酮、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-雙(4-胺基苯)六氟丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]碸、 1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,3-雙(3-胺基苯氧基)苯、9,9-雙(4-胺基苯)-10-氫蒽、2,7-二胺基芴、9,9-雙(4-胺基苯)芴、4,4’-亞甲基-雙(2-氯苯胺)、2,2’,5,5’-四氯-4,4’-二胺基聯苯、2,2’-二氯-4,4’-二胺基-5,5’-二甲氧基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、1,4,4’-(p-亞苯基異亞丙基)雙苯胺、4,4’-(m-亞苯基異亞丙基)雙苯胺、2,2’-雙[4-(4-胺基-2-三氟甲基苯氧基)苯]六氟丙烷、4,4’-二胺基-2,2’-雙(三氟甲基)聯苯、4,4’-雙[(4-胺基-2-三氟甲基)苯氧基]-八氟聯苯、二(4-胺基苯)聯苯胺、1-(4-胺基苯)-1,3,3-三甲基-1H-茚滿-5-胺、1,1-間苯二甲胺、1,3-丙二胺、四亞甲基二胺、戊二胺、六亞甲基二胺、庚二胺、辛二胺、壬二胺、1,4-環己二胺、異佛爾酮二胺、四氫化二環戊亞二烯基二胺、三環[6.2.1.02,7]-十一碳烯二甲基二胺、4,4’-亞甲基雙(環已胺)、1,3-雙(氨甲基)環己烷等脂肪族或脂環族二胺;以及2,3-二胺基吡啶、2,6-二胺基吡啶、3,4-二胺基吡啶、2,4-二胺基嘧啶、5,6-二胺基-2,3-二氰吡嗪、5,6-二胺基-2,4-二羥基嘧啶、2,4-二胺基-6-二甲基胺基-1,3,5-三嗪、1,4-雙(3-氨丙基)哌嗪、2,4-二胺基-6-異丙氧基-1,3,5-三嗪、2,4-二胺基-6-甲氧基-1,3,5-三嗪、2,4-二胺基-6-苯基-1,3,5-三嗪、2,4-二胺基-6-甲基-s-三嗪、2,4-二胺基-1,3,5-三嗪、4,6-二胺基-2-乙烯基-s-三嗪、2,4-二胺基-5-苯基噻唑、2,6-二胺基嘌呤、5,6-二胺基-1,3-二甲基脲嘧啶、3,5-二胺基-1,2,4-三唑、6,9-二胺基-2-乙氧基吖啶乳酸鹽 (6,9-diamino-2-ethoxy-acridine Lactate)、3,8-二胺基-6-苯基菲啶、1,4-二胺基哌嗪、3,6-二胺基吖啶、雙(4-胺基苯基)苯胺、1-(3,5-二胺基苯基)-3-癸基琥珀醯亞胺、1-(3,5-二胺基苯基)-3-辛基琥珀醯亞胺等在分子中具有兩個一級胺基且除了該等一級胺基之外還具有氮原子之二胺所構成之族群中之一種以上的二胺類化合物。 In the present invention, the diamine compound which can be used for obtaining polylysine is, for example, selected from p-phenylenediamine, m-phenylenediamine, 4,4'-diaminodiphenylmethane, 4,4. '-Diaminodiphenylethane, 4,4'-diaminodiphenyl sulfide, 4,4'-diaminodiphenyl hydrazine, 3,3'-dimethyl-4,4'-di Aminobiphenyl, 4,4'-diaminophenylbenzophenone, 4,4'-diaminodiphenyl ether, 1,5-diaminonaphthalene, 2,2'-dimethyl-4, 4'-Diaminobiphenyl, 5-amino-1-(4'-aminophenyl)-1,3,3-trimethylindan, 6-amino-1-(4'-amino group Benzene)-1,3,3-trimethylindan, 3,4'-diaminodiphenyl ether, 3,3'-diaminobenzophenone, 3,4'-diaminodiphenyl Methyl ketone, 4,4'-diaminobenzophenone, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 2,2-bis[4-(4-amine Phenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)phenyl]indole, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(3-aminophenoxy)benzene, 9, 9-bis(4-aminophenyl)-10-hydroquinone, 2,7-diaminopurine, 9,9-bis(4-aminophenyl)anthracene, 4,4'-methylene-bis ( 2-chloroaniline), 2,2',5,5'-tetrachloro-4,4' -diaminobiphenyl, 2,2'-dichloro-4,4'-diamino-5,5'-dimethoxybiphenyl, 3,3'-dimethoxy-4,4' -diaminobiphenyl, 1,4,4'-(p-phenylene isopropylidene)diphenylamine, 4,4'-(m-phenylene isopropylidene)diphenylamine, 2,2 '-Bis[4-(4-Amino-2-trifluoromethylphenoxy)benzene]hexafluoropropane, 4,4'-diamino-2,2'-bis(trifluoromethyl) Benzene, 4,4'-bis[(4-amino-2-trifluoromethyl)phenoxy]-octafluorobiphenyl, bis(4-aminophenyl)benzidine, 1-(4-amino group Benzene)-1,3,3-trimethyl-1H-indan-5-amine, 1,1-m-xylylenediamine, 1,3-propanediamine, tetramethylenediamine, pentamethylenediamine , hexamethylenediamine, heptanediamine, octanediamine, decanediamine, 1,4-cyclohexanediamine, isophoronediamine, tetrahydrobicyclopentadienyldiamine, tricyclic [6.2.1.0 2,7 ]-Decacenary dimethyldiamine, 4,4'-methylenebis(cyclohexylamine), 1,3-bis(aminomethyl)cyclohexane, etc. Or an alicyclic diamine; and 2,3-diaminopyridine, 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 5,6-diamine Base-2,3-cyanopyrazine, 5,6-diamino-2,4-dihydroxypyrimidine, 2,4-diamino-6-dimethylamino-1,3,5-three Pyrazine, 1,4-bis(3-aminopropyl)piperazine, 2,4-diamino-6-isopropoxy-1,3,5-triazine, 2,4-diamino-6 -Methoxy-1,3,5-triazine, 2,4-diamino-6-phenyl-1,3,5-triazine, 2,4-diamino-6-methyl-s -triazine, 2,4-diamino-1,3,5-triazine, 4,6-diamino-2-vinyl-s-triazine, 2,4-diamino-5-benzene Thiazole, 2,6-diaminoguanidine, 5,6-diamino-1,3-dimethyluracil, 3,5-diamino-1,2,4-triazole, 6,9 -6,9-diamino-2-ethoxy-acridine Lactate, 3,8-diamino-6-phenylphenanthridine, 1,4-diamine Piperazine, 3,6-diamino acridine, bis(4-aminophenyl)aniline, 1-(3,5-diaminophenyl)-3-mercaptosuccinimide, 1- a group consisting of (3,5-diaminophenyl)-3-octylsuccinimide, etc., having a primary amine group in the molecule and having a nitrogen atom in addition to the primary amine group One or more kinds of diamine compounds.

用於合成本發明之液晶配向劑中之聚醯胺酸或者聚醯亞胺的四羧酸二酐,可舉例為脂環四羧酸二酐、脂肪族四羧酸二酐及芳香族四羧酸二酐。 The tetracarboxylic dianhydride used for synthesizing the polyamic acid or the polyimine in the liquid crystal alignment agent of the present invention may, for example, be an alicyclic tetracarboxylic dianhydride, an aliphatic tetracarboxylic dianhydride or an aromatic tetracarboxylic acid. Acid dianhydride.

該脂環四羧酸二酐之具體例可為1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二氯-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、3,3’,4,4’-二環己基四羧酸二酐、順式-3,7-二丁基環辛-1,5-二烯-1,2,5,6-四羧酸二酐、2,3,5-三羧基環戊烷基乙酸二酐、5-(2,5-二氧代四氫-3-呋喃基)-3-甲基-3-環乙烯-1,2-二羧酸二酐、3,5,6-三羰基-2-羧基降冰片烯-2:3,5:6-二酐、2,3,4,5-四氫呋喃四羧酸二酐、1,3,3a,4,5,9b-六氫-5(四氫-2,5-二氧-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5-甲基-5(四氫-2,5-二氧-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5-乙基-5(四氫-2,5-二氧-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-7-甲基-5(四氫-2,5-二氧-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、 1,3,3a,4,5,9b-六氫-7-乙基-5(四氫-2,5-二氧-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-甲基-5(四氫-2,5-二氧-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-乙基-5(四氫-2,5-二氧-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5,8-二甲基-5(四氫-2,5-二氧-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、5-(2,5-二氧四氫呋喃基)-3-甲基-3-環乙烯-1,2-二羧酸酐、二環[2,2,2]-辛-7-烯-2,3,5,6-四羧酸二酐、3-氧雜二環[3,2,1]辛烷-2,4-二酮-6-螺-3’-(四氫呋喃-2’,5’-二酮)等。 Specific examples of the alicyclic tetracarboxylic dianhydride may be 1,2,3,4-cyclobutanetetracarboxylic dianhydride and 1,2-dimethyl-1,2,3,4-cyclobutane IV. Carboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-dichloro-1,2,3,4-cyclobutane tetracarboxylate Acid dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutane tetracarboxylic dianhydride, 1,2,3,4-cyclopentane tetracarboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,3',4,4'-dicyclohexyltetracarboxylic dianhydride, cis-3,7-dibutylcyclooctane-1 , 5-diene-1,2,5,6-tetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentaneacetic acid dianhydride, 5-(2,5-dioxotetrahydro-3 -furyl)-3-methyl-3-cycloethylene-1,2-dicarboxylic dianhydride, 3,5,6-tricarbonyl-2-carboxynorbornene-2:3,5:6-di Anhydride, 2,3,4,5-tetrahydrofuran tetracarboxylic dianhydride, 1,3,3a,4,5,9b-hexahydro-5(tetrahydro-2,5-dioxo-3-furanyl)- Naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-5-methyl-5(tetrahydro-2,5-dioxo -3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-5-ethyl-5 (tetrahydrogen) -2,5-dioxo-3-furanyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-7- Methyl-5 (tetrahydro-2,5-dioxo -3-furanyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-7-ethyl-5(tetrahydro-2,5-dioxo-3-furanyl)-naphtho[1,2-c]-furan- 1,3-diketone, 1,3,3a,4,5,9b-hexahydro-8-methyl-5(tetrahydro-2,5-dioxo-3-furanyl)-naphtho[1, 2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-8-ethyl-5(tetrahydro-2,5-dioxo-3-furanyl )-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-5,8-dimethyl-5(tetrahydro-2 ,5-dioxo-3-furanyl)-naphtho[1,2-c]-furan-1,3-dione, 5-(2,5-dioxotetrahydrofuranyl)-3-methyl-3 -cycloethylene-1,2-dicarboxylic anhydride, bicyclo[2,2,2]-oct-7-ene-2,3,5,6-tetracarboxylic dianhydride, 3-oxabicyclo[3 2,1]octane-2,4-dione-6-spiro-3'-(tetrahydrofuran-2',5'-dione) and the like.

該脂肪族四羧酸二酐之具體例可為丁烷四羧酸二酐等。該芳香族四羧酸二酐之具體例可為苯均四甲酸二酐、4,4’-聯苯四羧酸二酐(4,4’-Biphthalic dianhydride)、3,3’,4,4’-二苯甲酮四羧酸二酐、3,3’,4,4’-雙苯碸四羧酸二酐、1,4,5,8-萘四羧酸二酐、2,3,6,7-萘四羧酸二酐、3,3’,4,4’-二苯醚四羧酸二酐、3,3’,4,4’-二甲基二苯矽烷四羧酸二酐、3,3’,4,4’-四苯矽烷四羧酸二酐、1,2,3,4-呋喃四羧酸二酐、4,4’-雙(3,4-二羧基苯氧基)二苯硫醚二酐、4,4’-雙(3,4-二羧基苯氧基)二苯碸二酐、4,4’-雙(3,4-二羧基苯氧基)二苯基丙烷二酐、3,3’,4,4’-全氟異亞丙基二鄰苯二甲酸二酐、3,3’,4,4’-聯苯四羧酸二酐、雙(鄰苯二甲酸)苯基氧化膦二酐(bis(phthalic acid)phenyl phosphine oxide)、p-亞苯基-雙(三苯基鄰苯二甲酸)二酐、m-亞苯基-雙(三苯基鄰苯二甲酸)二酐、雙(三苯基鄰苯二甲酸)-4,4’-二苯基醚二酐、雙(三苯基鄰苯二甲酸)-4,4’-二苯基甲烷二酐、 乙二醇-雙(脫水偏苯三酸酯)、丙二醇-雙(脫水偏苯三酸酯)、1,4-丁二醇-雙(脫水偏苯三酸酯)、1,6-己二醇-雙(脫水偏苯三酸酯)、1,8-辛二醇-雙(脫水偏苯三酸酯)、2,2-雙(4-羥苯基)丙烷-雙(脫水偏苯三酸酯)等。 Specific examples of the aliphatic tetracarboxylic dianhydride may be butane tetracarboxylic dianhydride or the like. Specific examples of the aromatic tetracarboxylic dianhydride may be pyromellitic dianhydride, 4,4'-biphthalic dianhydride, 3,3', 4,4. '-benzophenone tetracarboxylic dianhydride, 3,3',4,4'-bisphenylindole tetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, 2,3, 6,7-naphthalenetetracarboxylic dianhydride, 3,3',4,4'-diphenyl ether tetracarboxylic dianhydride, 3,3',4,4'-dimethyldiphenylnonane tetracarboxylic acid Anhydride, 3,3',4,4'-tetraphenylnonanetetracarboxylic dianhydride, 1,2,3,4-furantetracarboxylic dianhydride, 4,4'-bis(3,4-dicarboxybenzene Oxy)diphenyl sulfide dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenyl phthalic anhydride, 4,4'-bis(3,4-dicarboxyphenoxy) Diphenylpropane dianhydride, 3,3',4,4'-perfluoroisopropylidene diphthalic dianhydride, 3,3',4,4'-biphenyltetracarboxylic dianhydride, double (phthalic acid) phenyl phosphine oxide, bis-phenylene-bis(triphenylphthalic acid) dianhydride, m-phenylene-bis ( Triphenylphthalic acid dianhydride, bis(triphenylphthalic acid)-4,4'-diphenyl ether dianhydride, bis(triphenylphthalic acid)-4,4'- Diphenyl Dianhydride, Ethylene glycol-bis(dehydrated trimellitate), propylene glycol-bis(hydrogen trimellitate), 1,4-butanediol-bis(hydrogen trimellitate), 1,6-hexane Alcohol-bis(hydrogen trimellitate), 1,8-octanediol-bis(anhydrotrimellitic acid ester), 2,2-bis(4-hydroxyphenyl)propane-bis(dehydrated trimellitate) Acid ester) and the like.

經由使該二胺類化合物與該四羧酸二酐反應,可獲得聚醯胺酸。 Polylysine can be obtained by reacting the diamine compound with the tetracarboxylic dianhydride.

用於該聚醯胺酸之合成反應的該四羧酸二酐和該二胺類化合物的使用比例如下:相對於二胺類化合物中的1當量胺基,該四羧酸二酐中之酸酐優選約為0.2至2當量,更優選約為0.7至1.2當量。 The use ratio of the tetracarboxylic dianhydride and the diamine compound used for the synthesis reaction of the polyamic acid is as follows: an acid anhydride in the tetracarboxylic dianhydride relative to 1 equivalent of an amine group in the diamine compound It is preferably about 0.2 to 2 equivalents, more preferably about 0.7 to 1.2 equivalents.

聚醯胺酸之合成反應,在有機溶劑中進行,可在-20℃至150℃的溫度條件下,優選在0℃至100℃的溫度條件下,反應時間為1小時至72小時,優選為3小時至48小時。 The synthesis reaction of polylysine is carried out in an organic solvent at a temperature of from -20 ° C to 150 ° C, preferably from 0 ° C to 100 ° C, for a reaction time of from 1 hour to 72 hours, preferably 3 hours to 48 hours.

此時,使用之有機溶劑沒有特別限制,只要使用能夠溶解所生成之聚醯胺酸者即可,例如可為N-甲基-2-吡咯烷酮、N,N-二甲基乙醯胺、N,N-二甲基甲醯胺、3-丁氧基-N,N-二甲基丙烷醯胺、3-甲氧基-N,N-二甲基丙烷醯胺、3-己氧基-N,N-二甲基丙烷醯胺等醯胺化合物;二甲亞碸、γ-丁內酯、四甲基尿素、六甲基磷醯三胺等之非質子化合物;以及m-甲酚、二甲苯酚、苯酚、苯酚鹵化物等苯酚化合物等。 In this case, the organic solvent to be used is not particularly limited as long as it is capable of dissolving the produced polyamic acid, and may be, for example, N-methyl-2-pyrrolidone, N,N-dimethylacetamide, N. , N-dimethylformamide, 3-butoxy-N,N-dimethylpropane decylamine, 3-methoxy-N,N-dimethylpropane decylamine, 3-hexyloxy- a guanamine compound such as N,N-dimethylpropane decylamine; an aprotic compound such as dimethyl hydrazine, γ-butyrolactone, tetramethyl urea, hexamethylphosphonium triamine; and m-cresol, a phenol compound such as xylenol, phenol or phenol halide.

另一方面,該有機溶劑在不析出所生成之聚醯胺酸之範圍內,可以同時使用醇、酮、酯、醚、鹵化碳氫化合物、碳氫化合物等聚醯胺酸之不良溶劑(poor solvent)。這種不 良溶劑之具體例可為甲醇、乙醇、異丙醇、環己醇、乙二醇、丙二醇、1,4-丁二醇、三甘醇、乙二醇單甲醚、乳酸乙酯、乳酸丁酯、丙酮、甲乙酮、甲基異丁基甲酮、環己酮、乙酸甲酯、乙酸乙酯、乙酸丁酯、甲氧基丙酸甲酯(Methyl methoxy propanoate)、乙氧基丙酸乙酯(ethyl ethoxy propanoate)、草酸二乙酯、丙二酸二乙酯、二乙醚、乙二醇甲醚、乙二醇乙醚、乙二醇-n-丙醚、乙二醇-i-丙醚、乙二醇-n-丁醚、乙二醇二甲醚、乙二醇乙醚乙酸酯、二甘醇二甲基醚、二甘醇二乙醚、二甘醇單甲醚、二甘醇單乙醚、二甘醇單甲醚乙酸酯、二甘醇單乙醚乙酸酯、四氫呋喃、二氯甲烷、1,2-二氯乙烷、1,4-二氯丁烷、三氯乙烷、氯苯、鄰二氯苯、己烷、庚烷、辛烷、苯、甲苯、二甲苯、丙酸異戊酯、丁酸異戊酯、二異戊醚等。如此,可獲得透過溶解聚醯胺酸而進行反應的反應溶液。之後,將此反應溶液加至大量不良溶劑中而獲得析出物,並在減壓條件下,透過乾燥此析出物或者用蒸發器減壓蒸餾並除去反應溶液而獲得聚醯胺酸。另外,可將此聚醯胺酸重新溶解於有機溶劑中,接著透過執行一次或多次之將用不良溶劑析出之製程或者用蒸發器減壓、蒸餾並除去之製程而純化聚醯胺酸。 On the other hand, the organic solvent can simultaneously use a poor solvent of a polylysine such as an alcohol, a ketone, an ester, an ether, a halogenated hydrocarbon or a hydrocarbon in the range of the polyamic acid formed without precipitation. Solvent). This kind of not Specific examples of the good solvent may be methanol, ethanol, isopropanol, cyclohexanol, ethylene glycol, propylene glycol, 1,4-butanediol, triethylene glycol, ethylene glycol monomethyl ether, ethyl lactate, lactic acid Ester, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, methyl acetate, ethyl acetate, butyl acetate, Methyl methoxy propanoate, ethyl ethoxy propionate Ethylene propanoate), diethyl oxalate, diethyl malonate, diethyl ether, ethylene glycol methyl ether, ethylene glycol ether, ethylene glycol-n-propyl ether, ethylene glycol-i-propyl ether, ethylene Alcohol-n-butyl ether, ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, two Glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, tetrahydrofuran, dichloromethane, 1,2-dichloroethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene, O-dichlorobenzene, hexane, heptane, octane, benzene, toluene, xylene, isoamyl propionate, isoamyl butyrate, diisoamyl ether, and the like. Thus, a reaction solution which reacts by dissolving polylysine can be obtained. Thereafter, the reaction solution is added to a large amount of poor solvent to obtain a precipitate, and the precipitate is obtained by drying the precipitate under reduced pressure or by vacuum distillation with an evaporator and removing the reaction solution to obtain polylysine. Alternatively, the polylysine may be redissolved in an organic solvent, and then the poly-proline may be purified by performing one or more processes of precipitating with a poor solvent or by a process of decompressing, distilling and removing with an evaporator.

透過將所獲得之該聚醯胺酸脫水閉環,以進行醯亞胺化而獲得聚醯亞胺。 Polyimine is obtained by dehydrating the obtained polylysine by ring closure to carry out oxime imidization.

進行該聚醯胺酸之脫水閉環的方式,優選地為(i)透過加熱聚醯胺酸之方法,或者(ii)將聚醯胺酸溶解於有機溶劑,並在此溶液中添加脫水劑及脫水閉環用之催化劑後, 根據需要加熱之方法來進行。在該(i)之加熱聚醯胺酸之方法中的反應溫度為50℃至200℃,優選為60℃至170℃。反應時間為1小時至8小時,優選為3小時至5小時。若反應溫度低於50℃,無法充分進行脫水閉環反應,若反應溫度超過200℃,有時會導致所獲得之聚醯亞胺的分子量變小。 The method for performing the dehydration ring closure of the polyamic acid is preferably (i) a method of permeating the poly-proline acid, or (ii) dissolving the poly-proline in an organic solvent, and adding a dehydrating agent to the solution. After the catalyst for dehydration ring closure, It is carried out according to the method of heating required. The reaction temperature in the method of heating the polyamic acid of (i) is from 50 ° C to 200 ° C, preferably from 60 ° C to 170 ° C. The reaction time is from 1 hour to 8 hours, preferably from 3 hours to 5 hours. When the reaction temperature is lower than 50 ° C, the dehydration ring closure reaction cannot be sufficiently performed, and if the reaction temperature exceeds 200 ° C, the molecular weight of the obtained polyimine may be small.

另一方面,在該(ii)在聚醯胺酸之溶劑中添加脫水劑及脫水閉環催化劑之方法中,脫水劑可使用例如乙酸酐、丙酸酐、三氟乙酸酐等酸酐。依據所要達成之醯亞胺化率,脫水劑之使用量有所不同,然而相對於1莫耳聚醯胺酸之醯胺酸結構,優選為0.01莫耳至20莫耳。 On the other hand, in the method of (ii) adding a dehydrating agent and a dehydration ring-closure catalyst to a solvent of polyproline, the dehydrating agent may be an acid anhydride such as acetic anhydride, propionic anhydride or trifluoroacetic anhydride. The amount of the dehydrating agent used varies depending on the imidization ratio to be achieved, but is preferably 0.01 mol to 20 mol per mol of the proline structure of 1 mol of polylysine.

而且,作為脫水閉環催化劑,可以使用例如吡啶、三甲吡啶、二甲吡啶、三乙胺等三級胺,但是並不限於此。脫水閉環催化劑之使用量,相對於所使用之1莫耳脫水劑,選為0.01莫耳至10莫耳。該脫水劑、脫水閉環劑之使用量越多,醯亞胺化率就會越高。用於脫水閉環反應之有機溶劑,可使用已被列舉可用於聚醯胺酸之合成的有機溶劑。 Further, as the dehydration ring-closure catalyst, for example, a tertiary amine such as pyridine, trimethylpyridine, dimethylpyridine or triethylamine can be used, but it is not limited thereto. The amount of the dehydration ring-closing catalyst used is selected from 0.01 mol to 10 mol with respect to the 1 mol dehydrating agent used. The more the amount of the dehydrating agent and the dehydration ring-closing agent used, the higher the yield of hydrazine. As the organic solvent used for the dehydration ring closure reaction, an organic solvent which has been enumerated for the synthesis of polyamic acid can be used.

脫水閉環反應之反應溫度為0℃至180℃,優選為10℃至150℃。反應時間為1小時至8小時,優選為3小時至5小時。在該方法(i)中所獲得之聚醯亞胺可直接用於製備液晶配向劑,或者可將所獲得之聚醯亞胺純化後,才使用於液晶配向劑的製備中。 The reaction temperature of the dehydration ring closure reaction is from 0 ° C to 180 ° C, preferably from 10 ° C to 150 ° C. The reaction time is from 1 hour to 8 hours, preferably from 3 hours to 5 hours. The polyimine obtained in the method (i) can be used directly for preparing a liquid crystal alignment agent, or the obtained polyimine can be purified before being used in the preparation of a liquid crystal alignment agent.

另一方面,在該方法(ii)中獲得之含聚醯亞胺的反應溶 液,可直接用於製備液晶配向劑,也可從該反應溶液中除去脫水劑以及脫水閉環催化劑後,才在液晶配向劑之製備中使用,也可分離聚醯亞胺後,才在液晶配向劑之製備中使用,或者純化所分離的聚醯亞胺後,才用於液晶配向劑之製備。從反應溶液中除去脫水劑及脫水閉環催化劑的方法,可應用例如溶劑置換等方法。聚醯亞胺之分離及純化,可透過與上述聚醯胺酸之分離及純化方法相同的方式進行。 On the other hand, the polyimine-containing reaction solution obtained in the method (ii) is dissolved. The liquid can be directly used for preparing the liquid crystal alignment agent, and can also be used in the preparation of the liquid crystal alignment agent after removing the dehydrating agent and the dehydration ring-closing catalyst from the reaction solution, and can also be separated in the liquid crystal alignment after the polyimine is separated. The preparation of the liquid crystal alignment agent is used after the preparation of the agent or the purification of the separated polyimine. As a method of removing the dehydrating agent and the dehydration ring-closure catalyst from the reaction solution, for example, a method such as solvent replacement can be applied. The separation and purification of the polyimine can be carried out in the same manner as the separation and purification of the above polyamic acid.

本發明之液晶配向劑包含有上述將四羧酸二酐與二胺類化合物反應而獲得之聚醯胺酸或者經過聚醯胺酸脫水閉環後而獲得之聚亞醯胺、光活性交聯化合物以及根據需要而加入之其他添加劑,優選地,該多種成分可透過溶解於有機溶劑而被包含在該液晶配向劑中。 The liquid crystal alignment agent of the present invention comprises the above polyamic acid obtained by reacting a tetracarboxylic dianhydride with a diamine compound or a polyamidamine obtained by dehydration ring closure of polyglycine, a photoactive crosslinking compound. And other additives added as needed, preferably, the plurality of components are contained in the liquid crystal alignment agent by being dissolved in an organic solvent.

可使用於本發明之液晶配向劑的有機溶劑例如可為N-甲基-2-吡咯烷酮、γ-丁內酯、γ-丁內醯胺、N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、4-羥基-4-甲基-2-戊酮、乙二醇單甲醚、乳酸丁酯、乙酸丁酯、甲氧基丙酸甲酯、乙氧基丙酸乙酯、乙二醇甲醚、乙二醇乙醚、乙二醇-n-丙醚、乙二醇-i-丙醚、乙二醇-n-丁醚(Butyl Cellosolve,或稱乙二醇單丁醚)、乙二醇二甲醚、乙二醇乙醚乙酸酯、二甘醇二甲基醚、二甘醇二乙醚、二甘醇單甲醚、二甘醇單乙醚、二甘醇單甲醚乙酸酯、二甘醇單乙醚乙酸酯、3-丁氧基-N,N-二甲基丙烷醯胺、3-甲氧基-N,N-二甲基丙烷醯胺、3-己氧基-N,N-二甲基丙烷醯胺等。 The organic solvent which can be used in the liquid crystal alignment agent of the present invention may be, for example, N-methyl-2-pyrrolidone, γ-butyrolactone, γ-butyrolactam, N,N-dimethylformamide, N, N-dimethylacetamide, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monomethyl ether, butyl lactate, butyl acetate, methyl methoxypropionate, ethoxypropyl Ethyl acetate, ethylene glycol methyl ether, ethylene glycol ether, ethylene glycol-n-propyl ether, ethylene glycol-i-propyl ether, ethylene glycol-n-butyl ether (Butyl Cellosolve, or ethylene glycol) Monobutyl ether), ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol Monomethyl ether acetate, diethylene glycol monoethyl ether acetate, 3-butoxy-N,N-dimethylpropane decylamine, 3-methoxy-N,N-dimethylpropane decylamine, 3-hexyloxy-N,N-dimethylpropane decylamine and the like.

在本發明之液晶配向劑中的固形物濃度(係指在液晶配向劑中,除溶劑以外之成分的合計重量,在液晶配向劑之總重量中所占比例),考慮黏性、揮發性等因素,必須適當地進行選擇,優選可為1重量%(wt%)至10重量%(wt%)之範圍。當該固形物之濃度低於1重量%(wt%)時,藉由塗覆液晶配向劑而形成之膜的厚度過薄,無法獲得良好的液晶配向膜,另一方面,當該固形物濃度超過10重量%(wt%)時,形成之膜的厚度過厚,同樣無法獲得良好之液晶配向膜,並且,液晶配向劑之黏性會增大,而降低塗覆特性。 The solid content concentration in the liquid crystal alignment agent of the present invention (the ratio of the total weight of the components other than the solvent in the liquid crystal alignment agent to the total weight of the liquid crystal alignment agent), considering viscosity, volatility, etc. The factor must be appropriately selected, and may preferably range from 1% by weight (% by weight) to 10% by weight (% by weight). When the concentration of the solid matter is less than 1% by weight (wt%), the thickness of the film formed by coating the liquid crystal alignment agent is too thin to obtain a good liquid crystal alignment film, and on the other hand, when the solid concentration is When the content exceeds 10% by weight (wt%), the thickness of the formed film is too thick, and a good liquid crystal alignment film is not obtained as well, and the viscosity of the liquid crystal alignment agent is increased to lower the coating characteristics.

根據本發明之一實施例,可透過在該聚醯胺酸中添加本發明之光活性交聯化合物而製備液晶配向劑。 According to an embodiment of the present invention, a liquid crystal alignment agent can be prepared by adding the photoactive crosslinking compound of the present invention to the polyamic acid.

此外,根據本發明之另一實施例,也可透過將該光活性交聯化合物添加於由聚醯胺酸獲得之聚醯亞胺中而製備液晶配向劑。 Further, according to another embodiment of the present invention, a liquid crystal alignment agent can also be prepared by adding the photoactive crosslinking compound to a polyimine obtained from polyamic acid.

當將UV照射於含有該光活性交聯化合物之液晶配向劑時,透過在該光活性交聯化合物之結構內的光反應基形成交聯結構,從而引導液晶配向膜實現有效的垂直配向。 When UV is applied to the liquid crystal alignment agent containing the photoactive crosslinking compound, a photoreactive group in the structure of the photoactive crosslinking compound forms a crosslinked structure, thereby guiding the liquid crystal alignment film to achieve effective vertical alignment.

該光活性交聯化合物能夠進一步提高所形成之液晶配向膜之預傾角的穩定性及膜強度,使其能夠在無摩擦狀態下,透過UV曝光即進行光配向。 The photoactive crosslinking compound can further improve the stability of the pretilt angle and the film strength of the formed liquid crystal alignment film, and can perform photoalignment by UV exposure in a frictionless state.

根據本發明之一實施例,相對於100重量份之該聚醯胺酸或者聚醯亞胺,該液晶配向劑可含有0.1重量份至40重量份之該光活性交聯化合物,優選地可含有0.1重量份至30重量份。若該光活性交聯化合物的含量低於0.1重量 份,則無法有提高垂直配向之效果,若該光活性交聯化合物的含量超過40重量份,則會降低液晶配向劑的基本性質。 According to an embodiment of the present invention, the liquid crystal alignment agent may contain 0.1 part by weight to 40 parts by weight of the photoactive crosslinking compound, preferably may contain, relative to 100 parts by weight of the polyaminic acid or polyimine. 0.1 parts by weight to 30 parts by weight. If the content of the photoactive crosslinking compound is less than 0.1 weight However, there is no effect of improving the vertical alignment, and if the content of the photoactive crosslinking compound exceeds 40 parts by weight, the basic properties of the liquid crystal alignment agent are lowered.

液晶配向膜及液晶顯示裝置Liquid crystal alignment film and liquid crystal display device

藉由將本發明之液晶配向劑塗覆於基材上,並進行加熱,可形成液晶配向膜。 The liquid crystal alignment film can be formed by applying the liquid crystal alignment agent of the present invention to a substrate and heating it.

該液晶配向劑可透過例如輥塗法、旋轉法、印刷法、噴墨法等方法進行塗覆,接著利用加熱塗覆表面而形成液晶配向膜。 The liquid crystal alignment agent can be applied by, for example, a roll coating method, a spin method, a printing method, an inkjet method, or the like, and then the surface is coated by heating to form a liquid crystal alignment film.

在塗覆液晶配向劑後,為了防止所塗覆之配向劑液體流動,優選地可執行預熱(預烤)。預烤溫度,優選為約30℃至約300℃,更優選為約40℃至約200℃,最優選為約50℃至約150℃。 After the liquid crystal alignment agent is applied, in order to prevent the flow of the applied alignment agent liquid, it is preferable to perform preheating (prebaking). The pre-bake temperature is preferably from about 30 ° C to about 300 ° C, more preferably from about 40 ° C to about 200 ° C, and most preferably from about 50 ° C to about 150 ° C.

此後,完全除去溶劑,並為了使聚醯胺酸熱醯亞胺化,可以執行燒成(後烤)製程。該燒成(後烤)溫度,優選為約80℃至約300℃,更優選為約120℃至約250℃。如此,也可透過塗覆包含聚醯胺酸之液晶配向劑,之後除去有機溶劑以形成即將成為液晶配向膜之塗膜,並且利用加熱進行脫水閉環,從而形成進一步被醯亞胺化的配向膜。所形成之液晶配向膜的膜厚,優選為約0.001 μm至約1 μm,更優選為約0.005 μm至約0.5 μm。 Thereafter, the solvent is completely removed, and in order to thermally imidize the polyglycolic acid, a firing (post-baking) process can be performed. The firing (post-baking) temperature is preferably from about 80 ° C to about 300 ° C, more preferably from about 120 ° C to about 250 ° C. Thus, the liquid crystal alignment agent containing poly-proline can also be applied, and then the organic solvent is removed to form a coating film which is to be a liquid crystal alignment film, and dehydration ring closure is performed by heating to form an alignment film which is further imidized. . The film thickness of the formed liquid crystal alignment film is preferably from about 0.001 μm to about 1 μm, more preferably from about 0.005 μm to about 0.5 μm.

可利用對乾燥後之塗膜表面照射波長範圍約150 nm至約450 nm之紫外線進行配向處理。此時,可以照射曝光強度為約50 mJ/cm2至約10 J/cm2之能量,優選照射約500 mJ/cm2至約5 J/cm2之能量。 The alignment treatment may be performed by irradiating the surface of the dried coating film with ultraviolet rays having a wavelength ranging from about 150 nm to about 450 nm. At this time, an energy having an exposure intensity of about 50 mJ/cm 2 to about 10 J/cm 2 may be irradiated, preferably an energy of about 500 mJ/cm 2 to about 5 J/cm 2 .

透過前述之光配向以及一系列過程之後,就能夠獲得具有優秀之熱穩定性與高配向性之液晶配向膜。 Through the aforementioned light alignment and a series of processes, a liquid crystal alignment film having excellent thermal stability and high alignment property can be obtained.

另外,可利用本發明所屬技術領域中的常規方法製備具有該液晶配向膜的液晶顯示裝置。例如,可透過在形成有液晶配向膜之兩個基板之外緣部塗覆樹脂黏合劑後,使液晶配向膜以面對面的狀態疊壓該兩個基板,並固化黏合劑,之後將液晶從液晶注入口注入基板之間,再密封液晶注入口來製備液晶顯示裝置。 Further, a liquid crystal display device having the liquid crystal alignment film can be prepared by a conventional method in the technical field to which the present invention pertains. For example, after the resin adhesive is applied to the outer edge portions of the two substrates on which the liquid crystal alignment film is formed, the liquid crystal alignment film is laminated in a face-to-face state, and the adhesive is cured, and then the liquid crystal is liquid crystal. The injection inlet is injected between the substrates, and the liquid crystal injection port is sealed to prepare a liquid crystal display device.

以下,經由實施例更詳細地說明本發明。對於本領域的技術人員來說,應不難理解這些實施例只是為了例示本發明,並不以這些實施例限定本發明之範圍。 Hereinafter, the present invention will be described in more detail by way of examples. It should be understood by those skilled in the art that these examples are not intended to limit the scope of the invention.

<實施例><Example> 製備光活性交聯化合物Preparation of photoactive crosslinking compounds 實施例1:製備化學式20(n=1,RExample 1: Preparation of Chemical Formula 20 (n=1, R 11 ~R~R 88 =H時)之光活性交聯化合物Photoactive cross-linking compound at =H)

將原料物質4,4,4-三氟丁烷-1-醇(4,4,4-trifluorobutan-1-ol)(化學式1)(95.0 g,0.74 mol)溶解於三乙胺(triethylamine,TEA)(135 mL,0.97 mol)與1 L二氯甲烷(Methylene Chloride,MC),並將其冷卻至0℃。於30分鐘內,在所生成的物質中緩慢地添加甲磺醯氯 (methanesulfonyl chloride,MsCl)(63.0 mL,62.0 mol)。在0℃下攪拌該混合物10分鐘,並在室溫下使之反應2小時,以製備甲磺酸4,4,4-三氟丁基酯(4,4,4-trifluorobutyl methanesulfonate)(化學式2)。 The starting material 4,4,4-trifluorobutan-1-ol (4,4,4-trifluorobutan-1-ol) (chemical formula 1) (95.0 g, 0.74 mol) was dissolved in triethylamine (TEA) (135 mL, 0.97 mol) and 1 L of dichloromethane (Methylene Chloride, MC) and cooled to 0 °C. Slowly add methanesulfonate chloride to the resulting material within 30 minutes (methanesulfonyl chloride, MsCl) (63.0 mL, 62.0 mol). The mixture was stirred at 0 ° C for 10 minutes and allowed to react at room temperature for 2 hours to prepare 4,4,4-trifluorobutyl methanesulfonate (Chemical Formula 2). ).

將對羥基苯甲酸甲酯(methyl-4-hydroxybenzoate)(化學式3)(87.3 g,0.57 mol)、K2CO3(95.2 g,0.69 mol)和甲磺酸4,4,4-三氟丁基酯(4,4,4-trifluorobutyl methanesulfonate)(化學式2)(130.3 g,0.63 mol)加至2 L乙腈(acetonitrile)中,並迴流(reflux)12小時。將反應物冷卻至常溫,並進行萃取,以製備化學式4之化合物。將化學式4之化合物(160 g,0.57 mol)加至1.5 L甲醇(methanol)中,添加370 mL之25%的氫氧化鈉(NaOH),使之反應4小時,以製備化學式5之化合物。 Methyl-hydroxybenzoate (Chemical Formula 3) (87.3 g, 0.57 mol), K 2 CO 3 (95.2 g, 0.69 mol) and 4,4,4-trifluoromethanesulfonate 4,4,4-trifluorobutyl methanesulfonate (Chemical Formula 2) (130.3 g, 0.63 mol) was added to 2 L of acetonitrile and refluxed for 12 hours. The reactant is cooled to normal temperature and subjected to extraction to prepare a compound of Chemical Formula 4. The compound of Chemical Formula 4 (160 g, 0.57 mol) was added to 1.5 L of methanol, and 370 mL of 25% sodium hydroxide (NaOH) was added thereto to carry out a reaction for 4 hours to prepare a compound of Chemical Formula 5.

在高壓釜中加入對-硝基肉桂酸(4-nitrocinnamic acid)(化學式6)(110 g,0.57 mol)、1.5 L甲醇、以及濕度為 50%之10%的Pd/C(11.0 g,10% w/w),並在氫氣(3 atm)氣氛中使之反應24小時,以製備化學式7之化合物。 In the autoclave, 4-nitrocinnamic acid (chemical formula 6) (110 g, 0.57 mol), 1.5 L of methanol, and humidity were added. 50% of 10% of Pd/C (11.0 g, 10% w/w) was reacted in a hydrogen (3 atm) atmosphere for 24 hours to prepare a compound of Chemical Formula 7.

將化學式7之化合物(95.0 g,0.57 mol)溶解於1,4-三氧雜環乙烷(1,4-dioxane)(1 L)/Na2CO3(120.6 g,在1.2 L的H2O中),並在0℃條件下添加Boc2O(149 g,0.68 mol)後,在室溫使之反應3小時,以製備化學式8之化合物(145 g,96%)。 The compound of formula 7 (95.0 g, 0.57 mol) was dissolved in 1,4-dioxane (1 L) / Na 2 CO 3 (120.6 g, at 1.2 L of H 2 After adding Boc 2 O (149 g, 0.68 mol) at 0 ° C, it was reacted at room temperature for 3 hours to prepare a compound of Chemical Formula 8 (145 g, 96%).

將化學式8之化合物(61.0 g,0.23 mol)和TEA(38.6 mL,0.27 mol)加至700 mL之DME中,並在0℃添加氯甲酸乙酯(ethyl chloroformate)(26.3 mL,0.27 mol)後使之反應24小時。將反應物冷卻至0℃,添加NaBH4(14.8 g,0.39 mol)。使混合物反應12小時,以獲得化學式9之化合物。 The compound of Chemical Formula 8 (61.0 g, 0.23 mol) and TEA (38.6 mL, 0.27 mol) were added to 700 mL of DME, and ethyl chloroformate (26.3 mL, 0.27 mol) was added at 0 °C. It was allowed to react for 24 hours. The reaction was cooled to 0 ℃, was added NaBH 4 (14.8 g, 0.39 mol ). The mixture was allowed to react for 12 hours to obtain a compound of Chemical Formula 9.

將化學式9之化合物(125 g)和PCC(196 g,0.91 mol)與矽膠(silica gel)(100 g)加至二氯甲烷(Methylene Chloride)(1.7 L)中,在室溫使之反應3小時,以製備化學式10之化合物(57.8 g)。 The compound of Chemical Formula 9 (125 g) and PCC (196 g, 0.91 mol) and silica gel (100 g) were added to dichloromethane (Methylene Chloride) (1.7 L), and reacted at room temperature 3 The compound of Chemical Formula 10 (57.8 g) was prepared in an hour.

將對-羥基苯乙酮(4-hydroxyacetophenone)(化學式11)(100 g,0.73 mol)溶解於EtOAc(1.5 L),在常溫條件下加入CuBr2(328 g,1.47 mol)。然後使之迴流(reflux)12小時,以製備化學式12之化合物。將化學式12之化合物(116 g,0.54 mol)和3,4-二氫-2H-吡喃(3,4-dihydro-2H-pyran)(200 mL,2.16 mol)加至含有PPTS(4.10 g,0.016 mol)之1.5 L二氯甲烷(Methylene Chloride)中,並在室溫使之反應4小時,以製備化學式13之化合物。 4-Hydroxyacetophenone (Chemical Formula 11) (100 g, 0.73 mol) was dissolved in EtOAc (1.5 L), and CuBr 2 (328 g, 1.47 mol) was added at room temperature. It was then refluxed for 12 hours to prepare a compound of Chemical Formula 12. The compound of Chemical Formula 12 (116 g, 0.54 mol) and 3,4-dihydro-2H-pyran (200 mL, 2.16 mol) were added to contain PPTS (4.10 g, 0.016 mol) of 1.5 L of dichloromethane (Methylene Chloride) was allowed to react at room temperature for 4 hours to prepare a compound of Chemical Formula 13.

將化學式13之化合物(175 g,0.54 mol)和PPh3(145 g,0.55 mol)加至乙腈(acetonitrile)(1.5L)中,在室溫條件下使之反應6小時,以製備化學式14之化合物。將化學式14之化合物(29 0g,0.52 mol)溶解於THF(2.5 L)之後,加入2 M之Na2CO3(2 L),使之反應12小時,以製備化學式15之化合物(226 g,91%)。 The compound of Chemical Formula 13 (175 g, 0.54 mol) and PPh 3 (145 g, 0.55 mol) were added to acetonitrile (1.5 L), and allowed to react at room temperature for 6 hours to prepare Chemical Formula 14 Compound. After dissolving the compound of Chemical Formula 14 (290 g, 0.52 mol) in THF (2.5 L), 2 M of Na 2 CO 3 (2 L) was added and reacted for 12 hours to prepare a compound of Chemical Formula 15 (226 g, 91%).

將化學式10之化合物(73.8 g,0.29 mol)以及在反應式4中所製備之化學式15的化合物(171 g,0.36 mol)溶解於甲苯(toluene),並迴流(reflux)7小時,以製備化學式16之化合物(102 g,76%)。 A compound of Chemical Formula 10 (73.8 g, 0.29 mol) and a compound of Chemical Formula 15 (171 g, 0.36 mol) prepared in Reaction Scheme 4 were dissolved in toluene and refluxed for 7 hours to prepare a chemical formula. Compound of 16 (102 g, 76%).

將化學式16之化合物(102 g,0.22 mol)溶解於2.0L二氯甲烷(Methylene Chloride),並在0℃條件下加入TFA(200 mL)1小時。在室溫使之反應4小時,以製備化學式17之化合物(70.2 g,91%)。 The compound of Chemical Formula 16 (102 g, 0.22 mol) was dissolved in 2.0 L of dichloromethane (Methylene Chloride), and TFA (200 mL) was added at 0 ° C for 1 hour. This was reacted at room temperature for 4 hours to prepare a compound of Chemical Formula 17 (70.2 g, 91%).

將化學式17之化合物(70.2 g,0.20 mol)溶解於200 mL之AcOH,並加入環氧氯丙烷(epichlorohydrin)(20.3 g,0.22 mol),使之反應12小時,以製備化學式18之化合物 (85.0 g,92%)。將化學式18之化合物(85.0 g,0.18 mol)和PPTS(5.67 g,0.02 mol)加入於甲醇中,使之反應4小時,以製備化學式19之化合物(60.0 g,88%)。 The compound of Chemical Formula 17 (70.2 g, 0.20 mol) was dissolved in 200 mL of AcOH, and epichlorohydrin (20.3 g, 0.22 mol) was added and reacted for 12 hours to prepare a compound of Chemical Formula 18 (85.0 g, 92%). A compound of Chemical Formula 18 (85.0 g, 0.18 mol) and PPTS (5.67 g, 0.02 mol) were added to methanol, and reacted for 4 hours to prepare a compound of Chemical Formula 19 (60.0 g, 88%).

將化學式19之化合物(60.0 g,0.16 mol)溶解於1 L二氯甲烷(Methylene Chloride),在10℃溫度下加入由反應式2所製備之化學式5的化合物(51.0 g,0.20 mol)、EDCI(45.9 g,0.25 mol)、DMAP(10.4 g,0.09 mol)和DIPEA(89.0 mL,0.51 mol)。在室溫條件下使之反應12小時後,萃取並獲得生成物,透過使用管柱層析[MC/EtOAc(20:1)]純化該生成物,以製備化學式20之化合物(91.4 g,94%)。 The compound of Chemical Formula 19 (60.0 g, 0.16 mol) was dissolved in 1 L of dichloromethane (Methylene Chloride), and the compound of Chemical Formula 5 (51.0 g, 0.20 mol) prepared by the reaction formula 2 was added at a temperature of 10 ° C, EDCI. (45.9 g, 0.25 mol), DMAP (10.4 g, 0.09 mol) and DIPEA (89.0 mL, 0.51 mol). After reacting for 12 hours at room temperature, the product was extracted and obtained, and the product was purified by column chromatography [MC / EtOAc (20:1)) to give the compound of formula 20 (91.4 g, 94). %).

實施例2:製備化學式40(n=1,RExample 2: Preparation of Chemical Formula 40 (n=1, R 11 ~R~R 44 =H時)之光活性交聯化合物Photoactive cross-linking compound at =H)

將對-羥基苯乙酮(4-hydroxyacetophenone)(化學式25)(72.5 g,0.53 mol)溶解於DMF(700 mL),使之與實施例1之反應式1所製備的甲磺酸4,4,4-三氟丁基酯(4,4,4-trifluorobutyl methanesulfonate)(化學式2)(152 g,0.64 mol)及K2CO3(110 g,0.80 mol)反應,以製備化學 式26之化合物(98.0 g,75%)。 4-Hydroxyacetophenone (Chemical Formula 25) (72.5 g, 0.53 mol) was dissolved in DMF (700 mL) to react with the methanesulfonic acid 4,4 prepared in Reaction Scheme 1 of Example 1. , 4,4,4-trifluorobutyl methanesulfonate (Chemical Formula 2) (152 g, 0.64 mol) and K 2 CO 3 (110 g, 0.80 mol) are reacted to prepare a compound of formula 26 ( 98.0 g, 75%).

將化學式26之化合物(98.0 g,0.4 mol)溶解於MC/MeOH(2:1,1.2 L),並在10℃溫度下緩慢地加入Bu4NBr2(192 g,0.4 mol)。使之反應12小時,以製備化學式27之化合物(120 g,93%)。 The compound of Chemical Formula 26 (98.0 g, 0.4 mol) was dissolved in MC/MeOH (2:1, 1.2 L), and Bu 4 NBr 2 (192 g, 0.4 mol) was slowly added at a temperature of 10 °C. This was allowed to react for 12 hours to prepare a compound of the formula 27 (120 g, 93%).

將化學式27之化合物(120 g,0.4 mol)加至亞磷酸三乙酯(triethylphosphite)(193 mL,1.11 mol),並迴流(reflux)4小時,以製備化學式28之化合物(60 g,43%)。 The compound of the formula 27 (120 g, 0.4 mol) was added to triethylphosphite (193 mL, 1.11 mol), and refluxed for 4 hours to prepare a compound of the formula 28 (60 g, 43%) ).

將二苯甲酮(benzophenone)(化學式29)(100 g,0.55 mol)和KOH(30.8 g,0.55 mol)加至乙腈(acetonitrile)(700 mL),並迴流(reflux)2小時,以製備化學式30之化 合物(98.0 g,87%)。在-78℃溫度和氮氣氣氛中,在乙腈(acetonitrile)(88.0 mL,1.67 mol)和THF(900 mL)之混合溶液中緩慢加入溶於己烷中之2.5 M的BuLi溶液(2.5 M solution in hexane)(480 mL,1.19 mol),攪拌3小時,再加入化學式30之化合物(98.0 g,0.48 mol)和THF(600 mL),並使之反應3小時,以製備化學式31之化合物(102 g,87%)。 Benzophenone (Chemical Formula 29) (100 g, 0.55 mol) and KOH (30.8 g, 0.55 mol) were added to acetonitrile (700 mL) and refluxed for 2 hours to prepare a chemical formula. 30 Compound (98.0 g, 87%). Slowly add a 2.5 M BuLi solution (2.5 M solution in hexane) in a mixture of acetonitrile (88.0 mL, 1.67 mol) and THF (900 mL) at a temperature of -78 ° C under a nitrogen atmosphere. Hexane) (480 mL, 1.19 mol), stirred for 3 hours, and then added a compound of formula 30 (98.0 g, 0.48 mol) and THF (600 mL), and allowed to react for 3 hours to prepare a compound of formula 31 (102 g , 87%).

將濃硫酸(Concentrated sulfuric acid)(460 mL)和發煙硝酸(fuming nitric acid)(69.1 mL)冷卻至0至-5℃之間,並加入化學式31之化合物(91.5 g,0.37 mol),在10℃溫度下使之反應5小時,以製備化學式32之化合物(103 g,83%)。在50% H2SO4(2 L,v/v)中加入化學式32之化合物(109 g,0.32 mol),並在150℃下使之反應後降低溫度至室溫。之後透過萃取反應物以製備化學式33之化合物。 Concentrated sulfuric acid (460 mL) and fuming nitric acid (69.1 mL) were cooled to between 0 and -5 ° C, and a compound of formula 31 (91.5 g, 0.37 mol) was added. This was reacted at 10 ° C for 5 hours to prepare a compound of Chemical Formula 32 (103 g, 83%). A compound of the formula 32 (109 g, 0.32 mol) was added to 50% H 2 SO 4 (2 L, v/v), and reacted at 150 ° C to lower the temperature to room temperature. The compound of Chemical Formula 33 is then prepared by extracting the reactants.

將化學式33之化合物(143 g,0.32 mol)溶解於EtOH(1 L),並加入HCl後,使之迴流(reflux)12小時,以製備化學式34之化合物(129 g,94%)。在高壓釜中加入化學式34之化合物(129 g,0.30 mol)、甲醇(1.5 L)和10% Pd/C(20 g,20% w/w),並在氫氣(3atm)氣氛下使之反應24小時,以製備化學式35之化合物。 The compound of Chemical Formula 33 (143 g, 0.32 mol) was dissolved in EtOH (1 L), and HCl was added, and then refluxed for 12 hours to prepare a compound of formula 34 (129 g, 94%). The compound of formula 34 (129 g, 0.30 mol), methanol (1.5 L) and 10% Pd/C (20 g, 20% w/w) were added to the autoclave and reacted under a hydrogen (3 atm) atmosphere. The compound of Chemical Formula 35 was prepared for 24 hours.

將化學式35之化合物(113 g,0.30 mol)溶解於300 mL之AcOH,並加入環氧氯丙烷(epichlorohydrine)(33.3 g,0.36 mol),使之反應12小時,以製備化學式36之化合物(148 g,83%)。將化學式36之化合物(148.6 g,0.25 mol) 溶解於EtOH(1 L),並加入NaOH(20 g,0.50 mol)水溶液之後,使之迴流(reflux)3小時,以製備化學式37之化合物(107.7 g,80%)。 The compound of the formula 35 (113 g, 0.30 mol) was dissolved in 300 mL of AcOH, and epichlorohydrine (33.3 g, 0.36 mol) was added and reacted for 12 hours to prepare a compound of the formula 36 (148). g, 83%). Compound of formula 36 (148.6 g, 0.25 mol) After dissolving in EtOH (1 L) and adding NaOH (20 g, 0.50 mol) aqueous solution, it was refluxed for 3 hours to prepare a compound of formula 37 (107.7 g, 80%).

將化學式37之化合物(107.7 g,0.20 mol)溶解於THF(1 L),並在0℃緩慢加入BH3SMe2(45.5 g,0.60 mol)後,在50℃下使之反應5小時,以製備化學式38之化合物。再將化學式38之化合物(91.9 g,0.18 mol)溶解於乙腈(1.5 L)溶液中,加入4-甲醯苯甲酸(4-formylbenzoic acid)(80.6 g,0.54 mol)、EDCI(148.4 g,0.72 mol)、DMAP(12.4 g,0.11 mol)及DIPEA(78.3 mL,0.45 mol),並在10℃溫度下使之反應,以製備化學式39之化合物(77.4 g,55%)。 The compound of the formula 37 (107.7 g, 0.20 mol) was dissolved in THF (1 L), and BH3SMe2 (45.5 g, 0.60 mol) was slowly added at 0 ° C, and then reacted at 50 ° C for 5 hours to prepare a chemical formula 38. Compound. Further, a compound of the formula 38 (91.9 g, 0.18 mol) was dissolved in an acetonitrile (1.5 L) solution, and 4-formylbenzoic acid (80.6 g, 0.54 mol), EDCI (148.4 g, 0.72) was added. Mol), DMAP (12.4 g, 0.11 mol) and DIPEA (78.3 mL, 0.45 mol) were reacted at 10 ° C to give the compound of formula 39 (77.4 g, 55%).

將由該反應式6所製備之化學式28之化合物(93.5 g,0.25 mol)溶解於DMF(600 mL),並加入分散有60% NaOH(9.72 g,0.25 mol)之DMF(400 mL)溶液,使之反應24小時。將其與溶有化學式39之化合物(77.4 g,0.10 mol)的DMF(600 mL)溶液相混合,並在室溫下使之反應14小時後,透過使用管柱層析法[己烷/乙酸乙酯(2:1)]進行純化,以製備化學式40之化合物(86.1 g,70%)。 The compound of Chemical Formula 28 (93.5 g, 0.25 mol) prepared in the reaction formula 6 was dissolved in DMF (600 mL), and a solution of 60% NaOH (9.72 g, 0.25 mol) in DMF (400 mL) was added thereto. The reaction was carried out for 24 hours. This was mixed with a solution of the compound of formula 39 (77.4 g, 0.10 mol) in DMF (600 mL), and allowed to react at room temperature for 14 hours, then by column chromatography [hexane/acetic acid] Ethyl ester (2:1)] was purified to give the compound of formula 40 (86.1 g, 70%).

製備液晶配向劑Preparation of liquid crystal alignment agent 實施例3Example 3

將0.75 g之4,4-亞甲基二胺(MDA)、1.02 g之對-苯二胺(p-PDA)和5.62 g之胆甾烷醇(3,5-二胺基苯甲酸酯,CDB),在氮氣氣氛下溶解於69.0 g之N-甲基-2-吡咯烷酮(NMP)中,然後在維持20℃的同時添加5.40 g之2,3,5-三羧基環戊烷基 乙酸酐(2,3,5-tricarboxy cyclopentyl acetic anhydride,TCAAH)。其後,添加46.0 g之γ-丁內酯(GBL),並使之反應24小時。反應後添加51.13 g之γ-丁內酯(GBL)、3.83g之N-甲基-2-吡咯烷酮(NMP)以及72.9 g之乙二醇單丁醚(BC),以獲得5 wt%之聚醯胺酸溶液。(黏性12 cP,25℃) 0.75 g of 4,4-methylenediamine (MDA), 1.02 g of p-phenylenediamine (p-PDA) and 5.62 g of cholesteryl (3,5-diaminobenzoate) , CDB), dissolved in 69.0 g of N-methyl-2-pyrrolidone (NMP) under a nitrogen atmosphere, and then added 5.40 g of 2,3,5-tricarboxycyclopentyl group while maintaining 20 ° C 2,3,5-tricarboxy cyclopentyl hydride anhydride (TCAAH). Thereafter, 46.0 g of γ-butyrolactone (GBL) was added and allowed to react for 24 hours. After the reaction, 51.13 g of γ-butyrolactone (GBL), 3.83 g of N-methyl-2-pyrrolidone (NMP) and 72.9 g of ethylene glycol monobutyl ether (BC) were added to obtain a 5 wt% poly Proline solution. (viscosity 12 cP, 25 ° C)

在此添加該實施例1之光活性交聯化合物,使該光活性交聯化合物之濃度為5 wt%,以製備液晶配向劑。 The photoactive crosslinking compound of this Example 1 was added thereto so that the concentration of the photoactive crosslinking compound was 5 wt% to prepare a liquid crystal alignment agent.

比較例1Comparative example 1

利用與實施例3相同的方法製備液晶配向劑,除了未添加前述光活性交聯化合物之外。 A liquid crystal alignment agent was prepared by the same method as in Example 3 except that the aforementioned photoactive crosslinking compound was not added.

製備液晶配向膜及液晶顯示裝置Preparation of liquid crystal alignment film and liquid crystal display device

用孔徑為1 μm之過濾裝置分別過濾由該實施例3以及比較例1所獲得之液晶配向劑。使用旋轉裝置,以500 rpm的轉速和10秒之旋轉時間以及1800 rpm的轉速和20秒之旋轉時間,在設置於玻璃基板一表面之具有ITO膜的透明導電膜上,分兩步驟塗覆該液晶配向劑,並透過在180℃下預固化(pre cure)60秒,以及在210℃下固化(main cure)20分鐘來除去溶劑,以形成塗膜。 The liquid crystal alignment agent obtained in Example 3 and Comparative Example 1 was separately filtered with a filter device having a pore size of 1 μm. Using a rotating device, at 500 rpm and a rotation time of 10 seconds, and a rotation speed of 1800 rpm and a rotation time of 20 seconds, the transparent conductive film having an ITO film disposed on one surface of the glass substrate was coated in two steps. The liquid crystal alignment agent was removed by pre-curing at 180 ° C for 60 seconds and main curing at 210 ° C for 20 minutes to form a coating film.

之後利用曝光裝置,以300 mJ/cm2,10 mW之強度曝光30秒,從而製備具有液晶配向膜之兩個基板。接著在前述兩個具有液晶配向膜之基板、具有液晶配向膜之各外緣部,塗覆包含有直徑為4 μm之氧化鋁球的環氧樹脂黏合劑後,使液晶配向膜面對面地將前述兩個基板疊壓,之後固化黏合劑。接著透過液晶注入口於基板之間填充向列相液 晶(ne 1.5601,no 1.4780)後,用丙烯酸類光固化黏合劑密封液晶注入口,以製備液晶顯示裝置。 Thereafter, the substrate was exposed to an intensity of 300 mJ/cm 2 and 10 mW for 30 seconds using an exposure apparatus to prepare two substrates having a liquid crystal alignment film. Then, after coating the outer edge portions of the two liquid crystal alignment films and the outer edge portions of the liquid crystal alignment film, an epoxy resin binder containing alumina balls having a diameter of 4 μm is applied, and the liquid crystal alignment film is faced to face to face. The two substrates are laminated and then the adhesive is cured. Then, the nematic liquid crystal (n e 1.5601, n o 1.4780) was filled between the substrates through the liquid crystal injection port, and then the liquid crystal injection port was sealed with an acrylic photocurable adhesive to prepare a liquid crystal display device.

<實驗例><Experimental example> 液晶顯示裝置之物性評價Physical property evaluation of liquid crystal display device 評價方法Evaluation method 1.黏性 Stickiness

在25℃下利用cannon黏度計測定動黏度,用比重計測定比重後,將兩個測定值相乘而計算黏度。 The dynamic viscosity was measured at 25 ° C using a cannon viscometer, and after measuring the specific gravity by a hydrometer, the two measured values were multiplied to calculate the viscosity.

2.預傾角 2. Pretilt angle

根據記載於文獻(T.J.Schffer等人發表於1980年J.,Appl.,Phys.,期刊,第19卷,第2013頁)之方法,用He-Ne激光,透過結晶旋轉法測定。 According to the method described in the literature (T.J. Schffer et al., 1980 J., Appl., Phys., Journal, Vol. 19, p. 2013), it was measured by a crystal rotation method using a He-Ne laser.

3.液晶之配向性 3. The alignment of liquid crystal

當接通/斷開液晶顯示裝置之電壓時,用顯微鏡觀察在液晶顯示裝置中有無異常液晶區域,當無異常液晶區域時,判斷為良好。 When the voltage of the liquid crystal display device was turned on/off, the presence or absence of an abnormal liquid crystal region in the liquid crystal display device was observed with a microscope, and it was judged to be good when there was no abnormal liquid crystal region.

4.電壓維持率 4. Voltage maintenance rate

對液晶顯示裝置施加5 V電壓60微秒後,測定解除施加電壓16.67毫秒後的電壓維持率。 After a voltage of 5 V was applied to the liquid crystal display device for 60 μsec, the voltage holding ratio after the application of the voltage of 16.67 msec was released was measured.

經由本發明之實施例3以及比較例1製備之液晶顯示裝置之物性評價結果如下表1所示。並且,曝光前後之照片如圖1及圖2所示。 The physical property evaluation results of the liquid crystal display devices prepared in Example 3 and Comparative Example 1 of the present invention are shown in Table 1 below. Moreover, photos before and after exposure are shown in FIGS. 1 and 2.

圖1顯示由本發明之實施例3所製備之液晶顯示裝置的液晶配向照片。圖1中左側為曝光前,右側為曝光後。 Fig. 1 is a view showing a liquid crystal alignment photograph of a liquid crystal display device prepared in Example 3 of the present invention. In Fig. 1, the left side is before exposure and the right side is after exposure.

圖2顯示由比較例1所製備之液晶顯示裝置的液晶配向照片。圖2中左側為曝光前,右側為曝光後。 2 shows a liquid crystal alignment photograph of the liquid crystal display device prepared in Comparative Example 1. In Fig. 2, the left side is before exposure and the right side is after exposure.

參照上表1、圖1以及圖2,根據本發明之實施例製備之液晶顯示裝置,由於曝光後特性良好,因此能夠確認其比由比較例製備之液晶顯示裝置更優秀之特性。而且,根據本發明之實施例所製備之液晶顯示裝置,在曝光後沒有觀察到任何晶疇(domain),由此可知配向狀態優秀,然而比較例之液晶顯示裝置在曝光前後之晶疇差異並不大,由此可知配向狀態不良。 With reference to the above Table 1, FIG. 1 and FIG. 2, the liquid crystal display device prepared according to the embodiment of the present invention can be confirmed to have better characteristics than the liquid crystal display device produced by the comparative example because of excellent post-exposure characteristics. Moreover, according to the liquid crystal display device prepared according to the embodiment of the present invention, no domain is observed after the exposure, and thus the alignment state is excellent. However, the crystal domain difference of the liquid crystal display device of the comparative example before and after the exposure is It is not so large that it is known that the alignment state is poor.

圖1顯示由本發明之實施例3所製備之液晶顯示裝置的液晶配向照片。 Fig. 1 is a view showing a liquid crystal alignment photograph of a liquid crystal display device prepared in Example 3 of the present invention.

圖2顯示由比較例1所製備之液晶顯示裝置的液晶配向照片。 2 shows a liquid crystal alignment photograph of the liquid crystal display device prepared in Comparative Example 1.

Claims (12)

一種光活性交聯化合物,係以下列化學式I表示, 該化學式I中,X1、X2、X3及X4中任意一個以上為,其餘為H;R1至R8為相同或者相異,且分別獨立地為選自H、CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個;A為或者B為或者n為1至20之整數。 A photoactive crosslinking compound represented by the following chemical formula I, In the chemical formula I, any one of X 1 , X 2 , X 3 and X 4 is And the rest are H; R 1 to R 8 are the same or different, and are independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, an alkyl group having 1 to 10 carbon atoms, and a carbon number. Any one of 1 to 10 alkoxy groups; A is or B is or n is an integer from 1 to 20. 如申請專利範圍第1項所述之光活性交聯化合物,該化學式I之化合物係選自下列化學式20、化學式22以及化學式24表示之化合物中的一種化合物: 該化學式20、22以及24中,R1至R8為相同或者相異,且分別獨立地為選自H、CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個;n為1至20之整數。 The photoactive crosslinking compound according to claim 1, wherein the compound of the formula I is selected from the group consisting of the following compounds of the formula 20, the formula 22 and the compound of the formula 24: In the chemical formulas 20, 22 and 24, R 1 to R 8 are the same or different, and are each independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, an alkyl group having 1 to 10 carbon atoms, And any one of alkoxy groups having 1 to 10 carbon atoms; n is an integer of 1 to 20. 一種光活性交聯化合物,係以下列化學式II表示, 該化學式II中,X1、X2、X3及X4中任意一個以上為,其餘為H;R1至R8為相同或者相異,且分別獨立地為選自H、CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個;A為或者B為或者n為1至20之整數。 A photoactive crosslinking compound represented by the following chemical formula II, In the chemical formula II, any one of X 1 , X 2 , X 3 and X 4 is And the rest are H; R 1 to R 8 are the same or different, and are independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, an alkyl group having 1 to 10 carbon atoms, and a carbon number. Any one of 1 to 10 alkoxy groups; A is or B is or n is an integer from 1 to 20. 如申請專利範圍第3項所述之光活性交聯化合物,該化學式II之化合物係由下列化學式40表示, 該化學式40中,R1至R4為相同或者相異,且分別獨立地為選自H、CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個;n為1至20之整數。 The photoactive crosslinking compound according to claim 3, wherein the compound of the formula II is represented by the following chemical formula 40, In the formula 40, R 1 to R 4 are the same or different, and are each independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, an alkyl group having 1 to 10 carbon atoms, and a carbon number. Any one of 1 to 10 alkoxy groups; n is an integer of 1 to 20. 一種液晶配向劑,包括有如申請專利範圍第1項至第4項中任一項所述之光活性交聯化合物,以及聚醯胺酸或者聚醯亞胺。 A liquid crystal alignment agent comprising the photoactive crosslinking compound according to any one of claims 1 to 4, and polylysine or polyimine. 如申請專利範圍第5項所述之液晶配向劑,其中相對於100重量份之該聚醯胺酸或者聚醯亞胺,該光活性交聯化合物的含量為0.1重量份至40重量份。 The liquid crystal alignment agent according to claim 5, wherein the photoactive crosslinking compound is contained in an amount of from 0.1 part by weight to 40 parts by weight per 100 parts by weight of the polyamic acid or polyimine. 如申請專利範圍第5項所述之液晶配向劑,其中該聚醯胺酸係透過使一二胺類化合物以及一四羧酸二酐反應 所製備。 The liquid crystal alignment agent according to claim 5, wherein the polyamic acid is reacted by reacting a monoamine compound and a tetracarboxylic dianhydride. Prepared. 如申請專利範圍第7項所述之液晶配向劑,其中該二胺類化合物包含有選自p-苯二胺、m-苯二胺、4,4’-二胺基二苯甲烷、4,4’-二胺基二苯乙烷、4,4’-二胺基二苯硫醚、4,4’-二胺基二苯碸、3,3’-二甲基-4,4’-二胺基聯苯、4,4’-二胺基苯醯替苯胺、4,4’-二胺基二苯醚、1,5-二胺基萘、2,2’-二甲基-4,4’-二胺基聯苯、5-胺基-1-(4’-胺基苯)-1,3,3-三甲基茚滿、6-胺基-1-(4’-胺基苯)-1,3,3-三甲基茚滿、3,4’-二胺基二苯醚、3,3’-二胺基二苯甲酮、3,4’-二胺基二苯甲酮、4,4’-二胺基二苯甲酮、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-雙(4-胺基苯)六氟丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]碸、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,3-雙(3-胺基苯氧基)苯、9,9-雙(4-胺基苯)-10-氫蒽、2,7-二胺基芴、9,9-雙(4-胺基苯)芴、4,4’-亞甲基-雙(2-氯苯胺)、2,2’,5,5’-四氯-4,4’-二胺基聯苯、2,2’-二氯-4,4’-二胺基-5,5’-二甲氧基聯苯、3,3’-二甲氧基-4,4’-二胺基聯苯、1,4,4’-(p-亞苯基異亞丙基)雙苯胺、4,4’-(m-亞苯基異亞丙基)雙苯胺、2,2’-雙[4-(4-胺基-2-三氟甲基苯氧基)苯]六氟丙烷、4,4’-二胺基-2,2’-雙(三氟甲基)聯苯、4,4’-雙[(4-胺基-2-三氟甲基)苯氧基]-八氟聯苯、二(4-胺基苯)聯苯胺、1-(4-胺基苯)-1,3,3-三甲基-1H-茚滿-5-胺、1,1-間苯二甲胺、1,3-丙二胺、四亞甲基二胺、戊二胺、六亞甲基二胺、庚二胺、辛二胺、壬二胺、1,4-環己二胺、 異佛爾酮二胺、四氫化二環戊亞二烯基二胺、三環[6.2.1.02,7]-十一碳烯二甲基二胺、4,4’-亞甲基雙(環已胺)、1,3-雙(氨甲基)環己烷、2,3-二胺基吡啶、2,6-二胺基吡啶、3,4-二胺基吡啶、2,4-二胺基嘧啶、5,6-二胺基-2,3-二氰吡嗪、5,6-二胺基-2,4-二羥基嘧啶、2,4-二胺基-6-二甲基胺基-1,3,5-三嗪、1,4-雙(3-氨丙基)哌嗪、2,4-二胺基-6-異丙氧基-1,3,5-三嗪、2,4-二胺基-6-甲氧基-1,3,5-三嗪、2,4-二胺基-6-苯基-1,3,5-三嗪、2,4-二胺基-6-甲基-s-三嗪、2,4-二胺基-1,3,5-三嗪、4,6-二胺基-2-乙烯基-s-三嗪、2,4-二胺基-5-苯基噻唑、2,6-二胺基嘌呤、5,6-二胺基-1,3-二甲基脲嘧啶、3,5-二胺基-1,2,4-三唑、6,9-二胺基-2-乙氧基吖啶乳酸鹽、3,8-二胺基-6-苯基菲啶、1,4-二胺基哌嗪、3,6-二胺基吖啶、雙(4-胺基苯基)苯胺、1-(3,5-二胺基苯基)-3-癸基琥珀醯亞胺以及1-(3,5-二胺基苯基)-3-辛基琥珀醯亞胺所構成之族群中之一種以上的二胺類化合物。 The liquid crystal alignment agent according to claim 7, wherein the diamine compound comprises a compound selected from the group consisting of p-phenylenediamine, m-phenylenediamine, 4,4'-diaminodiphenylmethane, 4, 4'-Diaminodiphenylethane, 4,4'-diaminodiphenyl sulfide, 4,4'-diaminodiphenyl hydrazine, 3,3'-dimethyl-4,4'- Diaminobiphenyl, 4,4'-diaminophenyl benzophenone, 4,4'-diaminodiphenyl ether, 1,5-diaminonaphthalene, 2,2'-dimethyl-4 , 4'-diaminobiphenyl, 5-amino-1-(4'-aminophenyl)-1,3,3-trimethylindan, 6-amino-1-(4'-amine Benzo)-1,3,3-trimethylindan, 3,4'-diaminodiphenyl ether, 3,3'-diaminobenzophenone, 3,4'-diaminodi Benzophenone, 4,4'-diaminobenzophenone, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 2,2-bis[4-(4- Aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)phenyl]indole , 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(3-aminophenoxy)benzene, 9 , 9-bis(4-aminophenyl)-10-hydroquinone, 2,7-diaminopurine, 9,9-bis(4-aminophenyl)anthracene, 4,4'-methylene-bis (2-chloroaniline), 2, 2', 5, 5'-four -4,4'-diaminobiphenyl, 2,2'-dichloro-4,4'-diamino-5,5'-dimethoxybiphenyl, 3,3'-dimethoxy -4,4'-diaminobiphenyl, 1,4,4'-(p-phenylene isopropylidene)diphenylamine, 4,4'-(m-phenylene isopropylidene) double Aniline, 2,2'-bis[4-(4-amino-2-trifluoromethylphenoxy)benzene]hexafluoropropane, 4,4'-diamino-2,2'-bis (three Fluoromethyl)biphenyl, 4,4'-bis[(4-amino-2-trifluoromethyl)phenoxy]-octafluorobiphenyl, bis(4-aminophenyl)benzidine, 1- (4-Aminophenyl)-1,3,3-trimethyl-1H-indan-5-amine, 1,1-m-xylylenediamine, 1,3-propanediamine, tetramethylene Amine, pentamethylenediamine, hexamethylenediamine, heptanediamine, octanediamine, decanediamine, 1,4-cyclohexanediamine, isophoronediamine, tetrahydrobicyclopentadienyl Diamine, tricyclo[6.2.1.0 2,7 ]-undecene dimethyldiamine, 4,4'-methylenebis(cyclohexylamine), 1,3-bis(aminomethyl) ring Hexane, 2,3-diaminopyridine, 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 5,6-diamino-2,3 - dicyanpyrazine, 5,6-diamino-2,4-dihydroxypyrimidine, 2,4-diamino-6-dimethylamino-1,3,5-triazine, 1,4 -bis(3-aminopropyl)perazine Pyrazine, 2,4-diamino-6-isopropoxy-1,3,5-triazine, 2,4-diamino-6-methoxy-1,3,5-triazine, 2 ,4-diamino-6-phenyl-1,3,5-triazine, 2,4-diamino-6-methyl-s-triazine, 2,4-diamino-1,3 , 5-triazine, 4,6-diamino-2-vinyl-s-triazine, 2,4-diamino-5-phenylthiazole, 2,6-diaminopurine, 5,6 -diamino-1,3-dimethyluracil, 3,5-diamino-1,2,4-triazole, 6,9-diamino-2-ethoxy acridine lactate, 3,8-Diamino-6-phenylphenanthridine, 1,4-diaminopiperazine, 3,6-diaminoacridine, bis(4-aminophenyl)aniline, 1-(3 And one or more of the group consisting of 5-(diaminophenyl)-3-mercaptosuccinimide and 1-(3,5-diaminophenyl)-3-octylsuccinimide Diamine compounds. 一種液晶配向膜,係由申請專利範圍第5項所述之液晶配向劑所形成。 A liquid crystal alignment film formed by the liquid crystal alignment agent described in claim 5 of the patent application. 一種液晶顯示裝置,具有如申請專利範圍第9項所述之液晶配向膜。 A liquid crystal display device having the liquid crystal alignment film according to claim 9 of the patent application. 一種光活性交聯化合物之製備方法,該光活性交聯化合物係由下列化學式20所表示,該製備方法包括以下步驟:使下列化學式19表示之化合物與下列化學式5表示之化合物反應, 該化學式5、19及20中,R1至R8為相同或者相異,且分別獨立地為選自H、CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個;n為1至20之整數。 A method for producing a photoactive crosslinking compound, which is represented by the following Chemical Formula 20, which comprises the steps of reacting a compound represented by the following Chemical Formula 19 with a compound represented by the following Chemical Formula 5, In the chemical formulas 5, 19 and 20, R 1 to R 8 are the same or different, and are each independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, an alkyl group having 1 to 10 carbon atoms, And any one of alkoxy groups having 1 to 10 carbon atoms; n is an integer of 1 to 20. 一種光活性交聯化合物之製備方法,該光活性交聯化合物係由下列化學式40所表示,該製備方法包括以下步驟:使下列化學式39表示之化合物與下列化學式28表示之化合物反應, 該化學式28、39及40中, R1至R4為相同或者相異,且分別獨立地為選自H、CN、NO2、CF3、鹵素、碳原子數為1至10之烷基、以及碳原子數為1至10之烷氧基中的任一個;n為1至20之整數。 A method for producing a photoactive crosslinking compound, which is represented by the following Chemical Formula 40, which comprises the steps of reacting a compound represented by the following Chemical Formula 39 with a compound represented by the following Chemical Formula 28, In the chemical formulas 28, 39 and 40, R 1 to R 4 are the same or different, and are each independently selected from the group consisting of H, CN, NO 2 , CF 3 , halogen, an alkyl group having 1 to 10 carbon atoms, And any one of alkoxy groups having 1 to 10 carbon atoms; n is an integer of 1 to 20.
TW101122507A 2011-06-23 2012-06-22 Photoactive crosslinking compound, method for preparing the same, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device TW201309751A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20110061213 2011-06-23

Publications (1)

Publication Number Publication Date
TW201309751A true TW201309751A (en) 2013-03-01

Family

ID=47423090

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101122507A TW201309751A (en) 2011-06-23 2012-06-22 Photoactive crosslinking compound, method for preparing the same, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device

Country Status (4)

Country Link
KR (1) KR20130001144A (en)
CN (1) CN103649199B (en)
TW (1) TW201309751A (en)
WO (1) WO2012177061A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI706981B (en) * 2013-07-05 2020-10-11 日商日產化學工業股份有限公司 Polymer composition, method for manufacturing substrate with liquid crystal alignment film, transverse electric field drive type liquid crystal display element, method for manufacturing liquid crystal display element, and liquid crystal alignment film for transverse electric field drive type liquid crystal display element

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101976864B1 (en) * 2013-08-22 2019-05-09 전북대학교산학협력단 Method for manufacturing liquid crystal display device and liquid crystal display device manufactured by using the same
WO2015026191A1 (en) * 2013-08-22 2015-02-26 전북대학교산학협력단 Liquid crystal alignment material, liquid crystal display device using same, and method for manufacturing liquid crystal display device
WO2016204178A1 (en) * 2015-06-16 2016-12-22 三菱化学株式会社 Alignment film, and composition for alignment films
KR102267591B1 (en) 2018-11-20 2021-06-18 주식회사 엘지화학 Liquid crystal alignment composition, method of preparing liquid crystal alignment film, and liquid crystal alignment film, liquid crystal display using the same
KR102382472B1 (en) * 2018-11-20 2022-04-01 주식회사 엘지화학 Cross-linking agent compound, crystal alignment composition comprising the same, method of preparing liquid crystal alignment film, and liquid crystal alignment film, liquid crystal display using the same
KR102267590B1 (en) 2018-11-20 2021-06-18 주식회사 엘지화학 Liquid crystal alignment composition, method of preparing liquid crystal alignment film, and liquid crystal alignment film, liquid crystal display using the same
KR102410008B1 (en) 2019-01-21 2022-06-16 주식회사 엘지화학 Liquid crystal alignment composition, and liquid crystal alignment film, liquid crystal display using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721799A (en) * 1986-03-03 1988-01-26 Amoco Corporation Epoxy resins based on tetraglycidyl diamines
US5112934A (en) * 1989-11-27 1992-05-12 The Dow Chemical Company Epoxy polymeric nonolinear optical materials based on glycidyl amines
DE69230067T2 (en) * 1991-03-01 2000-01-05 Dow Chemical Co Mesogenic glycidylamines
US6391441B1 (en) * 1997-11-13 2002-05-21 Teijin Limited Adhesive polyester film
CN101730862B (en) * 2007-08-02 2011-12-07 Jsr株式会社 Liquid crystal aligning agent, liquid crystal alignment film, method for producing the same, and liquid crystal display device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI706981B (en) * 2013-07-05 2020-10-11 日商日產化學工業股份有限公司 Polymer composition, method for manufacturing substrate with liquid crystal alignment film, transverse electric field drive type liquid crystal display element, method for manufacturing liquid crystal display element, and liquid crystal alignment film for transverse electric field drive type liquid crystal display element

Also Published As

Publication number Publication date
WO2012177061A2 (en) 2012-12-27
KR20130001144A (en) 2013-01-03
WO2012177061A3 (en) 2013-04-04
CN103649199B (en) 2015-11-25
CN103649199A (en) 2014-03-19

Similar Documents

Publication Publication Date Title
TWI531596B (en) Photo-alignment agent of liquid crystal, photo-alignment film of liquid crystal including the agent, and liquid crystal display including the film
TWI520985B (en) Liquid crystal alignment agent, liquid crystal alignment film and liguid crystal display element
TW201309751A (en) Photoactive crosslinking compound, method for preparing the same, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device
TWI427375B (en) Vertical alignment mode liquid crystal alignment agent and liquid crystal display device
TWI386434B (en) Liquid crystal orientation agent and liquid crystal display element
TWI480274B (en) Treated polymer for a liquid crystal alignment agent, preparation thereof and the use thereof
TW201343718A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI476489B (en) Liquid crystal aligning agent and liquid crystal display element
JP5041169B2 (en) Liquid crystal aligning agent and liquid crystal display element
TW200832019A (en) Liguid crystal alignment agent and liquid crystal display element
WO2015182894A1 (en) Photoreactive diamine monomer polymerization and lcd alignment film using same
TWI427103B (en) Liquid crystal aligning agent and liquid crystal display element
KR102016949B1 (en) Amine Compound, Method for Preparing the same, Liquid Crystal Alignment Agent, Liquid Crystal Alignment Film and Liquid Crystal Display Device
CN107880902B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display assembly
KR101990302B1 (en) Diamine Compound, Method for Preparing the same, Liquid Crystal Alignment Agent, Liquid Crystal Alignment Film and Liquid Crystal Display Device
KR100831155B1 (en) Composition for liquid crystal aligning, liquid crystal aligning layer manufactured by the same, and liquid crystal display comprising the same
TWI428370B (en) Liquid crystal aligning agent and liquid crystal display element
KR100969329B1 (en) Novel photoaligning diamine, photoalignment agent of liquid crystal including the same, photoalignment film of liquid crystal including the same, and liquid crystal display including the same
JP5019049B2 (en) Liquid crystal aligning agent and liquid crystal display element
TW201609629A (en) Diamine compound for liquid crystal alignment agent, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device
KR102629649B1 (en) Photoalignment composition
TWI457421B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
JP2000063515A (en) Polyamic acid, polyimide and liquid crystal aligning agent
TW200925181A (en) Liquid crystal alignmenting agent and transverse electric field type liquid crystal display element
TWI427102B (en) Liquid crystal alignment agent and liquid crystal display element